# iLearn CRI — Full Content Bundle > Comprehensive markdown bundle of all primary content from ilearncri.com. Updated 2026-05-03. iLearn Clinical Research Institute (iLearn CRI) is a Pune-based clinical research training institute. Source: https://ilearncri.com/ --- # Courses ## PG Diploma in Clinical Research in Pune **URL:** https://ilearncri.com/courses/pg-diploma-clinical-research/ **Duration:** 12 months **Mode:** classroom **Fees:** ₹1,68,000 (₹1.7 lakh) **Summary:** iLearn CRI's 12-month PG Diploma in Clinical Research covers ICH-GCP, CRA, pharmacovigilance, clinical data management, regulatory affairs, and medical writing — comprehensive industry training with placement support across Pune CROs. **Eligibility:** - B.Pharm, M.Pharm graduates - B.Sc / M.Sc in Life Sciences, Biotechnology, Microbiology - BDS, BHMS, BAMS, BPT, MBBS graduates - Final-year students (admission with conditional joining) **Syllabus:** - **Clinical Research Foundations (Month 1-2):** Drug development lifecycle: discovery to post-marketing; Phases of clinical trials I-IV in depth; Stakeholder ecosystem: sponsor, CRO, site, IRB/IEC, regulators; ICH-GCP E6(R3) — full curriculum; Indian regulatory framework: NDCT Rules 2019, Schedule Y; Global regulatory landscape: USFDA, EMA, MHRA, PMDA, NMPA - **Clinical Research Associate Skills (Month 3-4):** Site selection, qualification, and initiation; Site monitoring visits: SIV, RMV, COV; Source Data Verification (SDV) techniques; Risk-Based Quality Management (RBQM); Trial Master File (TMF) and Investigator Site File (ISF); Veeva Vault CTMS and Medidata Rave hands-on; Protocol deviation management - **Pharmacovigilance Practice (Month 5-6):** ICSR processing lifecycle; MedDRA and WHO-DD coding; Argus Safety Database hands-on; ARISg overview; Aggregate reports: PSUR, PBRER, DSUR; Signal detection and disproportionality analysis; Risk Management Plans - **Clinical Data Management (Month 7-8):** CDM lifecycle: study build to database lock; EDC platforms: Medidata Rave hands-on; CDISC standards: CDASH, SDTM, ADaM; SAS programming for clinical data; Discrepancy management and reconciliation; Database lock procedures - **Regulatory Affairs Essentials (Month 9-10):** CTD/eCTD structure and submission lifecycle; CDSCO submission workflow (SUGAM); USFDA pathways: IND, NDA, ANDA; EMA marketing authorisation procedures; Drug Master Files and ASMF; Post-approval lifecycle management - **Medical Writing Practice (Month 11):** Clinical Study Report (CSR) structure; Protocol writing — SPIRIT guidance; Patient narratives for SAEs; Manuscript and abstract writing; Plain-language summaries - **Career Specialisation & Placements (Month 12):** Specialisation pathway selection (CRA, PV, CDM, RA, MW); Resume calibration and portfolio building; Mock interviews — domain-specific; Pune CRO and pharma landscape briefings; Direct hiring partner introductions **Career outcomes:** - Clinical Research Associate: ₹ 4.0–5.5 LPA - Pharmacovigilance Associate: ₹ 3.6–4.5 LPA - Clinical Data Coordinator: ₹ 3.6–4.5 LPA - Regulatory Affairs Associate: ₹ 3.5–4.5 LPA - Associate Medical Writer: ₹ 4.5–6.5 LPA - Clinical Trial Coordinator: ₹ 3.6–4.5 LPA **Frequently asked questions:** *Q: Who should take the PG Diploma vs a specialised 6-month course?* A: The PG Diploma is for graduates who want comprehensive exposure across all major clinical research domains before specialising — typically because they're unsure which specific career (CRA, PV, CDM, RA, MW) suits them, or because they want a broader skill base for future career mobility. The 6-month specialised courses are for graduates already certain about their path. Both lead to placement, but the PG Diploma graduates often have more employer optionality at the offer stage. *Q: Is the PG Diploma recognised by employers?* A: Yes. Pune CRO and pharma employers recognise the PG Diploma as the most comprehensive iLearn CRI credential. The 12-month duration plus the breadth of hands-on platform training (Argus, Medidata Rave, Veeva Vault, eCTD tools) means PG Diploma graduates often start one band higher than 6-month specialised graduates and have wider role options. *Q: Can I work part-time during the PG Diploma?* A: The programme runs weekday evenings (6–9 PM) and full Saturdays, designed to allow continuation of part-time work. Many students hold part-time pharmacy or laboratory work during the diploma. The course load is heavy (assignments and platform practice) so full-time work is not advisable for most students, but part-time and freelance work is manageable. *Q: What is the placement rate for the PG Diploma?* A: Our PG Diploma placement rate is 95% within 4 months of completion, with average starting CTC of ₹4.2 LPA. The breadth of training means PG Diploma graduates typically have offers from multiple specialisation tracks (CRA, PV, CDM) and can choose the role that best fits their interests and long-term career goals. *Q: Will I become a specialist in any one area?* A: The PG Diploma builds working competence in all five major domains (CRA, PV, CDM, RA, MW). For deep specialisation in one area, graduates typically build that expertise on the job over the first 12–18 months. The breadth of the diploma is the strength — you can credibly interview for any clinical research role and choose the best offer rather than being locked to one path. ### Course narrative ## Why the PG Diploma is the most flexible clinical research credential The PG Diploma in Clinical Research is the most comprehensive credential we offer. Twelve months covering every major clinical research domain — CRA, pharmacovigilance, clinical data management, regulatory affairs, and medical writing — designed for graduates who want broad exposure before specialising, and for employers who want hires with cross-functional understanding. It is also the credential that gives graduates the most negotiating leverage at placement time. A PG Diploma graduate can credibly interview for any clinical research role; six-month course graduates are typically locked to one track. That optionality often translates into multiple offers and a better-fit final placement. For B.Pharm, M.Pharm, B.Sc Life Sciences, BDS, MBBS, and BPT graduates entering the field, the PG Diploma is the safest bet when you're still deciding which clinical research specialisation suits you best. ## What does the PG Diploma cover that the 6-month courses don't The 6-month specialised courses (CRA, Pharmacovigilance, CDM, Regulatory Affairs, Medical Writing) go deeper into one domain. The PG Diploma trades some depth for breadth — and adds three things the specialised courses cannot: **Cross-domain context.** A CRA who understands what data managers do escalates better. A medical writer who has worked with pharmacovigilance writers writes better DSURs. A regulatory affairs associate with CDM exposure designs better submission strategies. These cross-domain skills compound for the entire career. **Specialisation deferred.** Most graduates entering clinical research don't know whether they prefer field work (CRA), analytical work (CDM), writing (MW), regulatory strategy (RA), or safety (PV) until they have hands-on exposure. The PG Diploma lets you experience all five before choosing. **Multiple offers at placement.** PG Diploma graduates routinely receive offers across 2–3 different role types. This drives both the choice quality and the negotiation leverage. ## How the 12 months are structured The first two months cover **foundations** — drug development, ICH-GCP E6(R3), Indian and global regulatory frameworks. This is the conceptual base everything else builds on. Months 3–4 focus on **CRA skills** — site monitoring, SDV, RBQM, TMF/ISF management, with hands-on Veeva Vault CTMS and Medidata Rave training. Months 5–6 shift to **pharmacovigilance** — ICSR processing, MedDRA and WHO-DD coding, Argus hands-on, aggregate reports, and signal detection. Months 7–8 cover **clinical data management** — CDM lifecycle, EDC platforms, CDISC standards (CDASH, SDTM, ADaM), and SAS programming for clinical data. Months 9–10 build **regulatory affairs** competence — CTD/eCTD, CDSCO submissions, USFDA and EMA pathways, DMFs, and post-approval lifecycle management. Month 11 covers **medical writing** practice — CSR sections, protocol writing, patient narratives, and a manuscript draft. Month 12 is **specialisation selection and placement preparation** — domain-specific resume calibration, mock interviews tailored to the chosen track, and direct hiring partner introductions. ## What makes this PG Diploma different Most PG Diplomas in India trade depth for length — they cover everything superficially without building real working competence in any domain. Our PG Diploma is structured so that each domain gets six weeks of focused, hands-on training that matches our specialised 6-month course depth at 70% completeness. By month 12, you have real working competence across all five domains, hands-on portfolios in EDC, Argus, eCTD, and CDM tools, and a clear specialisation path chosen with full information. The faculty rotates by domain — every module is taught by a practicing professional in that domain (a Senior CRA for the CRA module, a Senior Regulatory Manager for RA, a Senior Medical Writer for MW). You are never taught a domain by someone who isn't actively practicing in it. ## Placement outcomes PG Diploma placement rate is 95% within 4 months of completion. Average starting CTC of ₹4.2 LPA. Multiple-offer rate (graduates receiving 2+ offers across different role types) is approximately 60% — significantly higher than specialised course graduates. The placement team works with our full network of 50+ pharma and CRO hiring partners across Pune, with structured introductions tailored to the specialisation track each graduate chooses in month 12. ## Apply for the next batch PG Diploma batches begin twice a year (January and July) at our Wakad campus, with batch sizes capped at 30 students. The course runs weekday evenings (6–9 PM) and full Saturdays. Reach out on WhatsApp to discuss your background and the next intake batch. --- ## Pharmacovigilance Course in Pune **URL:** https://ilearncri.com/courses/pharmacovigilance/ **Duration:** 6 months **Mode:** classroom **Fees:** ₹84,000 (₹0.8 lakh) **Summary:** iLearn CRI offers a 6-month industry-led Pharmacovigilance course in Pune covering ICSR processing, signal detection, Argus & ARISg hands-on, and PV reporting—with direct placement support at Pune's pharma & CRO partners. **Eligibility:** - B.Pharm or M.Pharm graduates - B.Sc / M.Sc in Life Sciences, Biotechnology, Microbiology - BDS, BHMS, BAMS, BPT graduates - Working professionals seeking pharma transition **Syllabus:** - **Foundations of Pharmacovigilance:** History and evolution of drug safety surveillance; Pharmacovigilance regulatory framework: WHO-UMC, CDSCO, USFDA, EMA; Indian pharmacovigilance programme (PvPI); Key terminology: ADR, AE, SAE, AESI, signal, causality; Stakeholders in drug safety ecosystem - **ICSR Processing & Case Management:** Individual Case Safety Report (ICSR) lifecycle; Case intake, triage, and prioritization; MedDRA coding and WHO-DD coding; Narrative writing for ICSRs; Quality review and reconciliation; E2B(R3) and electronic submission standards - **Argus Safety Database — Hands-on:** Argus interface walkthrough and case entry; Workflow management and case assignment; Querying and reporting in Argus; Periodic report generation; User roles and access management - **ARISg & Veeva Vault Safety:** ARISg case processing fundamentals; Veeva Vault Safety platform overview; Comparative analysis: Argus vs ARISg vs Veeva Vault; Migration projects and database transitions - **Aggregate Reporting & Signal Detection:** Periodic Safety Update Reports (PSURs); Periodic Benefit-Risk Evaluation Reports (PBRERs); Development Safety Update Reports (DSURs); Signal detection methodologies; Disproportionality analysis (PRR, ROR, EBGM); Risk Management Plans (RMPs) - **Regulatory & Compliance:** ICH E2A-E2F guidelines in depth; Schedule Y of Drugs and Cosmetics Act; Good Pharmacovigilance Practices (GVP); Audit and inspection readiness; Pharmacovigilance System Master File (PSMF) - **Career Preparation & Placements:** Resume preparation for PV roles; Mock interviews with PV team leads; Pune pharma & CRO landscape briefing; Direct introductions to hiring partners **Career outcomes:** - Pharmacovigilance Associate: ₹ 3.6–4.2 LPA - Drug Safety Associate: ₹ 3.8–4.5 LPA - ICSR Case Processor: ₹ 3.5–4.0 LPA - Aggregate Report Writer: ₹ 4.5–6.0 LPA - Signal Detection Analyst: ₹ 5.0–7.5 LPA - PV Quality Reviewer: ₹ 4.0–5.5 LPA **Frequently asked questions:** *Q: Is the pharmacovigilance course worth it after B.Pharm?* A: Pharmacovigilance is one of the highest-demand entry paths into pharma for B.Pharm graduates in India. With Pune housing major PV operations of Cipla, Lupin, Mylan, Wockhardt, and large CROs like Syngene and Veeda, fresh B.Pharm graduates with structured PV training start at ₹ 3.5–4.5 LPA, with rapid growth to senior PV roles within 18–24 months. *Q: What is the difference between Argus and ARISg in this course?* A: Both are leading drug safety databases used by pharma companies and CROs. Argus (by Oracle) holds the largest market share globally and is dominant in Indian pharma. ARISg (by ArisGlobal) is widely used by mid-sized companies. Our course gives hands-on exposure to both, plus an overview of newer platforms like Veeva Vault Safety so you’re prepared for any employer’s tech stack. *Q: Do you provide MedDRA training?* A: Yes. MedDRA coding is a critical skill for ICSR processing. The course covers MedDRA hierarchy (SOC, HLGT, HLT, PT, LLT), coding conventions, and version migration scenarios with practical exercises. *Q: Will I get a job placement after completing the course?* A: Our placement record is 92% within 6 months of course completion. Every student goes through structured placement preparation: resume review, 3 rounds of mock interviews with practicing PV professionals, and direct introductions to our 50+ pharma and CRO partners across Pune. Final placement depends on individual performance, but the support infrastructure is comprehensive. *Q: Can I do this course while working?* A: Our flagship batch is classroom-based weekday evenings (6–9 PM) and Saturday full-day, designed for working professionals to attend without leaving their current job. Hybrid options with limited online sessions are available for select batches—contact admissions for the current schedule. *Q: What is the difference between PV and Clinical Research Associate (CRA) roles?* A: Pharmacovigilance focuses on drug safety throughout a product’s lifecycle—before approval (clinical trial safety) and after (post-marketing surveillance). CRAs focus on running clinical trials—site monitoring, protocol compliance, source data verification. PV is largely office-based with structured workflows; CRA involves regular travel to clinical trial sites. Both are valid entry careers; choice depends on whether you prefer analytical desk work (PV) or field-based trial management (CRA). ### Course narrative ## Why pharmacovigilance is the smartest first job in pharma If you are a B.Pharm, B.Sc, or M.Pharm graduate looking to enter the pharmaceutical industry in 2026, pharmacovigilance offers the most consistent, scalable career path available right now. The reasons are structural. Every drug sold globally must be monitored for safety throughout its lifecycle—from first-in-human trials to decades after market launch. Indian pharma exports are growing, large CROs are expanding their PV operations in Pune, and regulators worldwide are tightening safety reporting timelines. The result: a permanent, growing demand for trained pharmacovigilance professionals, and a domain where your skills compound rapidly because the work is structured, regulated, and process-driven. For Pune specifically, the opportunity is concentrated. The Hinjewadi-Wakad-Bhosari pharma corridor houses PV operations for **Cipla, Lupin, Mylan, Sun Pharma, Wockhardt, Glenmark**, and large CROs including **Syngene, Veeda Clinical Research, Lambda Therapeutic Research, and Reliance Life Sciences**. A trained PV professional in Pune is hired faster, paid better, and has more lateral movement than almost any other entry-level pharma role. ## What you will actually do as a PV professional Pharmacovigilance is often misunderstood. It is not lab-based, and it does not require a PhD. The day-to-day work centers on three activities: **Individual Case Safety Reports (ICSRs).** Every adverse event reported about a drug—from a clinical trial, a hospital, a healthcare professional, or a patient—must be processed into a standardized report and submitted to regulators within tight timelines (often 7 or 15 calendar days). You receive the case, code the medical terms, write a clinical narrative, assess causality, and submit electronically. **Aggregate reports.** Periodically, all the cases for a drug get rolled up into PSURs, PBRERs, or DSURs—long, detailed safety reviews submitted to regulators. As you grow, you write and review these. **Signal detection.** When a new adverse event pattern emerges, statisticians and PV scientists investigate whether it represents a real safety risk requiring label changes or even drug withdrawal. This is the most analytical part of the field, and the highest-paid. You work in a global drug safety database—**Oracle Argus** at most large pharma, **ARISg** at mid-sized CROs, increasingly **Veeva Vault Safety** at modern biotech. Our course teaches all three so you walk into any employer ready. ## How this course is structured The 6-month program is built around how PV is actually practiced in industry, not how it is taught in academic textbooks. The first 8 weeks build foundations: regulatory framework, terminology, ICSR lifecycle, and MedDRA coding. The middle 12 weeks are hands-on platform training—you process real anonymized cases in Argus and ARISg under faculty supervision, exactly the way you would in your first job. The final 4 weeks cover aggregate reporting, signal detection, and intensive placement preparation. Faculty are practicing PV professionals, not academic instructors. The lead curriculum designer has 10+ years across Pune CROs and currently consults for pharmacovigilance system audits. Module instructors are senior PV scientists, ICSR processors, and team leads from Pune's pharma corridor. You learn from people who close cases every day. ## Placement infrastructure Most clinical research institutes treat placement as an afterthought—a notice board, a placement officer, and a hope. We treat it as the deliverable. Every student completes structured placement preparation in the final month: resume review against PV-specific criteria, three rounds of mock interviews with hiring managers from partner companies, and direct introductions to our 50+ pharma and CRO partners. Most placements happen via warm referral within 30–60 days of course completion. Our placement rate is **92% within 6 months of course completion**, with starting CTCs ranging from ₹3.5 LPA (case processor roles at CROs) to ₹6+ LPA (specialized roles for M.Pharm graduates with prior internship experience). ## Who this course is right for You will get the most out of this program if you are: - A **fresh graduate** (B.Pharm, M.Pharm, B.Sc, M.Sc, BDS, BHMS) looking for a structured first job in pharma - A **working professional** in adjacent fields (medical writing, regulatory affairs, clinical research) wanting to add PV to your skillset - Someone returning to work after a break who wants a remote-friendly, process-driven role - A career-switcher from healthcare (nursing, paramedical) with a relevant qualification You may not be the right fit if you are looking for a research-oriented or wet-lab career, or if you cannot commit to the full 6-month timeline. ## Apply for the next batch Batches start every quarter at our Wakad campus. Seats are limited to 24 per batch to maintain hands-on platform access and faculty attention. Early applications get priority for placement preparation and corporate partner introductions. Reach out via WhatsApp for an immediate conversation about your background and the right intake batch for you. --- ## Clinical Research Associate (CRA) Training in Pune **URL:** https://ilearncri.com/courses/clinical-research-associate-cra/ **Duration:** 6 months **Mode:** classroom **Fees:** ₹96,000 (₹1.0 lakh) **Summary:** iLearn CRI's 6-month CRA training in Pune covers ICH-GCP, site monitoring, protocol management, and source data verification. ICH-GCP-aligned curriculum with placement support across Pune's CRO ecosystem. **Eligibility:** - B.Pharm, M.Pharm graduates - BDS, MBBS, BHMS, BAMS graduates - B.Sc / M.Sc Life Sciences (Botany, Zoology, Biotech, Microbiology) - BPT, Nursing graduates with relevant background **Syllabus:** - **Foundations of Clinical Research:** Drug development lifecycle: from discovery to post-marketing; Phases of clinical trials (Phase I-IV); Stakeholders: sponsor, CRO, site, IRB/IEC, regulators; Indian and global clinical research landscape; Career pathways for a Clinical Research Associate - **ICH-GCP & Regulatory Framework:** ICH-GCP E6(R3) guidelines in depth; Declaration of Helsinki and ethical foundations; Schedule Y and New Drugs and Clinical Trials Rules 2019 (India); 21 CFR Parts 50, 54, 56, 312 (USFDA); EU Clinical Trials Regulation; Informed consent process and documentation - **Site Selection & Initiation:** Site qualification and feasibility assessments; Site initiation visit (SIV) preparation and conduct; Investigator brochure review; Essential documents and Trial Master File (TMF); Investigator Site File (ISF) management - **Site Monitoring (Hands-on):** Routine monitoring visit (RMV) workflow; Source Data Verification (SDV) techniques; Risk-Based Quality Management (RBQM); Centralized vs on-site monitoring; Monitoring report writing; Protocol deviation identification and management - **Trial Management & Tools:** EDC platforms: Medidata Rave, Oracle InForm overview; CTMS (Clinical Trial Management Systems); Veeva Vault CTMS hands-on; Clinical supplies management; Vendor management - **Safety & Compliance:** SAE reporting timelines and processes; Audit readiness and inspection management; CAPA development; Quality Assurance vs Quality Control; GCP audit findings and remediation - **Closeout & Career Preparation:** Site close-out visit (COV) procedures; Final data review and database lock; Resume preparation for CRA roles; Mock interviews with practicing CRAs and CRO project managers; Direct hiring partner introductions **Career outcomes:** - Clinical Research Associate (Level I): ₹ 4.0–5.5 LPA - Clinical Trial Coordinator: ₹ 3.6–4.5 LPA - Site Coordinator: ₹ 3.5–4.2 LPA - Clinical Data Reviewer: ₹ 3.8–4.8 LPA - CRA Level II (after 18-24 months): ₹ 6.5–9.0 LPA **Frequently asked questions:** *Q: What does a Clinical Research Associate actually do?* A: A CRA monitors clinical trials at hospital and research sites to ensure they follow the protocol, ICH-GCP guidelines, and applicable regulations. The work involves regular visits to investigator sites, verifying that data recorded in the Case Report Form matches the source documents (SDV), reviewing protocol compliance, ensuring SAE reporting is timely, and writing detailed monitoring reports for the sponsor or CRO. CRAs are the field operators of clinical research. *Q: Do CRAs travel a lot?* A: Field-based CRAs typically travel 50-70% of the time to investigator sites. Pune-based CRAs cover sites across Maharashtra, Gujarat, Karnataka, and sometimes broader India. Travel is usually 2-3 days per site visit, with reporting and remote work in between. With the rise of risk-based monitoring, some roles have shifted to centralized/remote monitoring, reducing travel—but classical site monitoring still involves significant travel. *Q: What is the difference between CRA and Clinical Research Coordinator (CRC)?* A: A CRC works at the site (hospital or research institute) helping the principal investigator run the trial day-to-day—consenting patients, scheduling visits, completing CRFs. A CRA works for the sponsor or CRO and monitors multiple sites to ensure protocol compliance. CRC roles are easier to enter (less travel, hospital-based) but have a lower ceiling. CRA roles pay better, travel more, and have a clearer growth path to project management. *Q: Is ICH-GCP certification included in this course?* A: Yes. The curriculum is fully aligned with ICH-GCP E6(R3), the latest revision, and culminates in a comprehensive ICH-GCP assessment. We also prepare students for external GCP certifications (TransCelerate-recognized) which are increasingly required by sponsors and CROs. *Q: Can BDS or MBBS graduates take this course?* A: Absolutely—medical and dental graduates are highly valued in CRA roles because their clinical understanding accelerates protocol comprehension and SDV efficiency. Many of our top placements (sponsor-side CRA roles, medical monitor positions) go to BDS and MBBS graduates. *Q: What are the major employers for CRAs in Pune?* A: Pune is a CRO hub with major operations of Syngene International, Veeda Clinical Research, Lambda Therapeutic Research, ICON plc, IQVIA, Parexel, and Reliance Life Sciences. Sponsor-side opportunities at Cipla, Sun Pharma, Lupin, and Glenmark are also available. The market is competitive but growing, with steady hiring across all CRO levels. ### Course narrative ## Why CRA is the gold standard of clinical research careers The Clinical Research Associate is the most coveted entry path in clinical research—and for good reason. CRAs are the operators who make clinical trials run. They visit hospital sites, ensure patients are protected, verify data integrity, and confirm that the science meets the regulatory bar required to bring a new drug to market. A trained CRA in Pune commands strong starting compensation, builds a globally portable skillset, and has clearer career progression than most pharma roles. Within 18–24 months, a CRA Level I typically promotes to CRA Level II with a near-doubling of CTC. Senior CRAs at large CROs in Pune earn ₹15+ LPA, and Clinical Project Managers cross ₹25 LPA within 6–8 years. The role is demanding. CRAs travel, manage tight protocol timelines, handle escalations from sponsors and sites, and operate in a heavily regulated environment where mistakes have real consequences. But for graduates with the right temperament—organized, detail-oriented, comfortable with regulated work and travel—it is one of the most rewarding career paths in Indian pharma. ## What this course teaches Our 6-month CRA training builds the full operational skillset of a Clinical Research Associate, sequenced exactly the way trials run. You will learn to **read and interpret clinical trial protocols**, the foundational document of any trial. You will understand **ICH-GCP E6(R3)** at a working level—not just the principles, but how each principle translates into the specific actions a CRA takes during a monitoring visit. You will conduct **simulated site monitoring visits** with real-world case studies adapted from active trials. You will perform **Source Data Verification** on training datasets, write **monitoring visit reports** to industry templates, and practice **risk-based monitoring** workflows that modern CROs use. You will get **hands-on exposure to Veeva Vault CTMS** and walk through Medidata Rave EDC—the two platforms that dominate Indian CRO operations. By the time you complete the course, you will have processed simulated cases, reviewed protocols, and written monitoring reports under faculty mentorship. ## What makes this CRA course different Most CRA training in India is theoretical. You read about Source Data Verification in a textbook, complete an online quiz, and walk out with a certificate that does not translate into a job offer. We rebuilt the curriculum around how Pune CROs actually hire and onboard CRAs. Our faculty includes: - A **CRA Level III** with 8+ years across Syngene and a global CRO, currently leading site monitoring for a Phase III oncology trial - A **Clinical Project Manager** with 12 years of CRO experience, who personally trains the protocol management module - A **GCP auditor** who conducts inspection-readiness audits for sponsor companies, who teaches our compliance and audit module These instructors do not teach from PowerPoints alone. They teach from the actual cases, escalations, and protocol amendments they handled last quarter. ## Placement support, not placement promises Our placement infrastructure for CRAs is structured around three pillars: **Resume calibration.** CRA hiring is heavily resume-screened. Our placement team rewrites every student's resume to match what hiring managers at Pune CROs actually look for—therapeutic area exposure, ICH-GCP familiarity, EDC system mentions, and clear quantification of any prior trial-adjacent experience. **Mock interviews with practicing CRAs.** Three rounds: protocol comprehension, scenario-based monitoring questions, and behavioral. Every interview is conducted by a current CRA or CRO project manager, with detailed feedback after each round. **Direct hiring partner introductions.** We work with 50+ pharma and CRO companies in Pune. Top performers are introduced directly to hiring managers, often bypassing initial screening rounds. ## Apply for the next batch CRA training is intensive and we keep batches small (24 students max) to maintain quality. Batches begin every quarter at our Wakad campus. Reach out on WhatsApp to discuss your background and the next intake batch. --- ## Clinical Data Management Course in Pune **URL:** https://ilearncri.com/courses/clinical-data-management/ **Duration:** 4 months **Mode:** classroom **Fees:** ₹72,000 (₹0.7 lakh) **Summary:** iLearn CRI's 4-month Clinical Data Management course in Pune covers EDC platforms (Medidata Rave, Oracle Clinical), CDISC standards, SAS programming, database lock, and Pune CRO placement support. **Eligibility:** - B.Pharm, M.Pharm graduates - B.Sc / M.Sc in Life Sciences, Statistics, Computer Science, Bioinformatics - BDS, BHMS, BAMS graduates seeking analytical pharma careers - Working professionals from data analytics or pharma backgrounds **Syllabus:** - **Foundations of Clinical Data Management:** CDM lifecycle: study build to database lock; Roles: data manager, data reviewer, database programmer; Indian and global CDM landscape; ICH-GCP E6(R3) data integrity principles; ALCOA+ data quality framework - **Case Report Form (CRF) Design:** Annotated CRF (aCRF) structure; CRF Completion Guidelines (CCG); Edit checks specification; Form library design and reuse; Protocol-to-CRF mapping workshops - **EDC Platforms — Medidata Rave Hands-on:** Rave architecture and study build; Form designer and field validation; User roles and study access management; Data entry, queries, and source verification; Rave reports and metrics dashboards - **Oracle Clinical & InForm Overview:** Oracle Clinical study setup; InForm vs Rave — when to use which; Migration projects between platforms; Oracle integration with safety databases - **CDISC Standards:** CDASH (Clinical Data Acquisition Standards Harmonization); SDTM (Study Data Tabulation Model) deep-dive; ADaM (Analysis Data Model) overview; Define-XML and Reviewer's Guide preparation; Mapping legacy data to CDISC formats - **SAS Programming for CDM:** Base SAS for clinical data; PROC SQL for CRF data extraction; Data step processing for derivations; Macros for repeatable CDM workflows; SAS validation programming basics - **Data Cleaning, Queries & Reconciliation:** Discrepancy management lifecycle; Manual review and edit check resolution; External data reconciliation (lab, ECG, IRT); Coding dictionaries: MedDRA, WHO-DD; SAE reconciliation between safety and CDM databases - **Database Lock & Career Preparation:** Pre-lock checklist and quality review; Database lock procedures; Post-lock unlock workflows; Resume preparation for CDM roles; Mock interviews with practicing data managers; Direct hiring partner introductions **Career outcomes:** - Clinical Data Coordinator: ₹ 3.6–4.5 LPA - Clinical Data Associate: ₹ 4.0–5.5 LPA - EDC Study Builder: ₹ 4.5–6.0 LPA - Data Reviewer: ₹ 3.8–5.0 LPA - SAS Programmer (Clinical): ₹ 5.5–7.5 LPA - Senior CDM (after 3-4 years): ₹ 9.0–12.0 LPA **Frequently asked questions:** *Q: What does a Clinical Data Manager actually do?* A: A CDM is responsible for the integrity of all data collected in a clinical trial. The work includes designing the Case Report Form, building the EDC database, setting up edit checks, reviewing incoming data, raising and resolving queries with sites, reconciling external data (lab, ECG, IRT), and preparing the database for lock. It is heavily process-driven, regulated work where data accuracy directly impacts whether the trial's results are accepted by regulators. *Q: Is CDM better than CRA as a starting career?* A: Both are valid clinical research entry paths with different temperaments. CDM is office-based, analytical, and involves working in EDC platforms and SAS — better suited for graduates who like structured technical work. CRA is field-based with significant travel and direct site interaction. CDM has slower travel-related friction and a clearer technical specialization path (toward SAS programming or biostatistics), while CRA has a faster compensation ceiling at senior levels. *Q: Which EDC platforms are covered in this course?* A: The course gives hands-on training in Medidata Rave (the Indian CRO market leader) and overview-level training in Oracle Clinical/InForm and Veeva Vault EDC. You will build study forms, configure edit checks, run dummy data through workflows, and produce reports in Rave — exactly the skills hiring managers test in CDM interviews. *Q: Do I need to know SAS before joining?* A: No. The course includes Base SAS and PROC SQL training tailored for clinical data. You won't become a senior SAS programmer in 4 months, but you'll learn enough to extract CRF data, write basic derivations, and read existing SAS code — which is the level expected of a Clinical Data Coordinator or Associate. *Q: What is CDISC and why is it important?* A: CDISC is the global data standards body for clinical research. SDTM (study data tabulation) and ADaM (analysis data) are mandatory submission formats for FDA and increasingly CDSCO submissions. Knowing CDISC is what separates a generic data analyst from a clinical data professional. The course covers CDASH, SDTM, ADaM, and Define-XML preparation. *Q: Who hires CDM professionals in Pune?* A: Pune's CDM employer base includes Syngene International, Veeda Clinical Research, Lambda Therapeutic Research, ICON plc, IQVIA, Parexel, and the in-house clinical data teams of Cipla, Sun Pharma, Lupin, and Glenmark. CDM is also one of the most remote-friendly clinical research roles, so opportunities aren't limited to Pune-based employers — global CROs hire CDM staff for India delivery centres. ### Course narrative ## Why Clinical Data Management is the technical backbone of clinical research Every clinical trial generates thousands of data points — vital signs, lab values, adverse events, dosing records, patient outcomes. None of that data is useful unless it is captured cleanly, reviewed rigorously, locked at the right moment, and submitted in the formats regulators require. That is the work of a Clinical Data Manager. In a world where one bad dataset can sink a multi-year drug approval, CDM is the discipline that protects the integrity of the entire trial. For B.Pharm, B.Sc, and graduates with an analytical bent, CDM is one of the most overlooked but well-paid entry paths in pharma. Pune's CRO ecosystem has steady demand for trained CDM professionals, with starting CTCs of ₹3.6–4.5 LPA and clear progression to ₹10+ LPA within four years if you specialise in SAS programming or move into senior data review roles. ## What you will actually do as a Clinical Data Manager CDM work breaks down into four phases that map to a trial's lifecycle. **Study build.** Before any patient enrols, you build the database. This means designing the Case Report Form to match the protocol, setting up edit checks that catch data entry errors, writing CRF Completion Guidelines, and validating the build through user acceptance testing. Most CDM hires start as junior contributors on study build for 6–12 months. **Data collection and cleaning.** Once enrolment begins, data flows in from sites. Your job is to review every entry, raise queries when something looks off, work with site coordinators to resolve discrepancies, and reconcile external data feeds (central lab, ECG vendor, IRT). This is the bulk of day-to-day CDM work. **Coding and reconciliation.** Adverse events get coded into MedDRA. Concomitant medications get coded into WHO-DD. SAEs reported in safety databases must reconcile with what the CDM database shows. These are precision tasks where mistakes have real downstream consequences. **Database lock.** When enrolment closes and data is clean, the database is locked for analysis. You execute the pre-lock checklist, generate final reports, and hand over to biostatistics. This is the high-stakes moment of every trial. ## The Pune CDM market in 2026 Pune is a major Indian CDM hub, second only to Bangalore in CRO data delivery operations. The dominant employers: - **Syngene International** — large CDM team supporting Bristol Myers Squibb, Baxter, and other sponsor accounts - **Veeda Clinical Research** — generics-heavy CDM portfolio with rapid growth in oncology and biosimilars - **Lambda Therapeutic Research** — bioequivalence focus with structured CDM workflows - **IQVIA, ICON, Parexel** — global CRO India delivery centres with significant CDM headcount - **Cipla, Sun Pharma, Lupin, Glenmark** — sponsor-side CDM teams supporting in-house trials Most of these companies hire 20–60 CDM associates per quarter, with a clear pipeline from junior data coordinator to senior data reviewer to lead data manager. ## What this course teaches The 4-month curriculum is built around how Pune CROs actually do CDM work, sequenced from study build through database lock. You will **design Case Report Forms** for sample protocols and walk them through the formal review cycle. You will get **hands-on Medidata Rave training** — building forms, configuring edit checks, entering data, and running reports. You will write **annotated CRFs** and **CRF Completion Guidelines** to industry templates. The middle portion of the course shifts to **CDISC standards**. You will learn SDTM domain mapping, the difference between CDASH and SDTM, and how ADaM is built on top of SDTM for analysis. By the end, you can read a Define-XML and explain what a Reviewer's Guide is — the kind of knowledge that separates a generic data analyst from a clinical data professional. You will also get a structured introduction to **SAS programming** for CDM — Base SAS, PROC SQL for CRF extraction, and basic data step derivations. You will not become a senior SAS programmer in 4 months, but you will be conversant enough to handle the data reviewer level of SAS work that most early-career CDM roles require. The final weeks cover **discrepancy management, MedDRA and WHO-DD coding, SAE reconciliation, and database lock procedures**, plus intensive placement preparation. ## Why graduates choose this CDM course Most CDM training in India is theoretical — you read about edit checks in a slide deck and watch screen recordings of Rave. Our curriculum is built around live datasets, real Rave study builds, and instructor-led case studies adapted from active CDM operations. Faculty includes a **Senior Clinical Data Manager** with 9 years across IQVIA and Syngene who teaches the EDC and reconciliation modules, a **CDISC SME** who has led SDTM mappings for 30+ submissions, and a **Clinical SAS Programmer** with a regulatory submission portfolio across CDSCO and FDA. These instructors do not teach from textbooks. They teach from the actual study builds, edit check failures, and lock-day escalations they handled in the last quarter. ## Placement support for CDM roles CDM hiring is heavily resume-screened and skills-tested. Our placement infrastructure addresses both: **Resume calibration.** Every student's resume is rewritten to highlight EDC platform exposure, CDISC familiarity, SAS basics, and any quantifiable CRF or data review work — the exact signals CDM hiring managers screen for. **Hands-on portfolio.** You complete a full Rave study build, an SDTM mapping exercise, and a query lifecycle case study during the course. These become work samples you can show interviewers — most candidates from competing institutes have nothing concrete to demonstrate. **Mock interviews with practicing data managers.** Three rounds: technical (EDC and SAS), scenario-based (discrepancy resolution and reconciliation), and behavioural. Every interview is conducted by a current CDM at a Pune CRO. **Direct hiring partner introductions.** Our placement team works actively with 50+ pharma and CRO companies. Top performers are introduced directly to hiring managers, often bypassing initial screens. ## Apply for the next batch CDM is a precision discipline and we keep batches small (24 students max) to maintain quality. Batches begin every quarter at our Wakad campus. Reach out on WhatsApp to discuss your background and the next intake batch. --- ## Medical Coding Course in Pune **URL:** https://ilearncri.com/courses/medical-coding/ **Duration:** 3 months **Mode:** classroom **Fees:** ₹42,000 (₹0.4 lakh) **Summary:** iLearn CRI's 3-month Medical Coding course in Pune covers ICD-10-CM, CPT, HCPCS, anatomy refresh, and AAPC CPC exam prep — with structured placement at MNC payers, hospitals, and remote/freelance pathways. **Eligibility:** - Any life-sciences graduate (B.Pharm, B.Sc, B.Sc Nursing, BPT) - BDS, BHMS, BAMS, MBBS graduates - Working professionals seeking remote-friendly pharma careers - 12+2 PCB students with strong English (limited seats) **Syllabus:** - **Medical Coding Foundations:** Healthcare reimbursement ecosystem (US, UK, India); Why medical coding exists: claim cycle and revenue cycle management; Roles: coder, auditor, denials specialist, CDI; Career pathways: in-house vs MNC vs freelance; Compliance frameworks: HIPAA, OIG - **Anatomy & Medical Terminology Refresh:** Body systems overview (cardiovascular, respiratory, GI, MSK, neuro); Medical terminology: prefixes, suffixes, root words; Pharmacology basics for coders; Common diagnostic procedures and laboratory tests; Reading physician notes and operative reports - **ICD-10-CM Coding:** ICD-10-CM structure: chapters, blocks, categories, codes; Official Coding Guidelines; Coding conventions: includes, excludes1, excludes2, NEC, NOS; Coding by body system with hands-on cases; Sequencing principal vs secondary diagnoses; Z-codes, V-codes, and external cause codes - **CPT Coding:** CPT structure: Categories I, II, III; E/M services coding (2021 + 2023 guideline updates); Surgery section coding: integumentary, MSK, cardiovascular, GI; Modifier usage (-25, -26, -59, -76, -78, -79); Bundling and unbundling concepts; Anesthesia, radiology, pathology, and lab coding - **HCPCS Level II:** HCPCS structure and J-codes; DME (durable medical equipment) coding; Drug administration codes; Modifiers specific to HCPCS - **Specialty Coding (Hands-on):** ED (emergency department) coding; Inpatient vs outpatient differences; Surgery coding case studies; Risk Adjustment / HCC coding overview; Denial management workflows - **AAPC CPC Exam Preparation:** CPC exam structure: 100 questions, 4 hours; Time-management strategies; Practice exams with AAPC-style questions; Review sessions on weak areas; Test-day logistics (online proctoring, scheduling) - **Career Preparation & Placements:** Resume preparation for coder roles; Interview prep: live coding tests; Remote/freelance career setup; Hiring partner introductions **Career outcomes:** - Medical Coder (Trainee): ₹ 2.8–3.6 LPA - CPC-Certified Medical Coder: ₹ 3.6–5.0 LPA - Senior Medical Coder (3-5 yrs): ₹ 5.5–7.5 LPA - Coding Auditor / QA: ₹ 6.0–8.5 LPA - Risk Adjustment / HCC Coder: ₹ 5.5–8.0 LPA - Freelance Medical Coder (remote): ₹ 4.0–9.0 LPA (variable) **Frequently asked questions:** *Q: Is medical coding a good career in India?* A: Medical coding is one of the most consistently hiring healthcare-adjacent roles in India. The work is largely outsourced from US payers and providers to Indian operations centres, so demand is structural and growing. Salaries start modest (₹3–4 LPA) but grow quickly with CPC certification, and the role is one of the few in the pharma/healthcare space that allows full remote or freelance work — making it especially attractive for caregivers, parents, or graduates in non-metro cities. *Q: Do I need to clear the AAPC CPC exam to get a job?* A: Most large MNC employers (Optum, Cognizant, Omega Healthcare, Access Healthcare, Sutherland) hire CPC-certified coders at significantly higher salaries than uncertified ones. CPC adds ₹50,000–₹1,00,000 to your starting CTC and is worth the investment. Our course includes structured CPC exam preparation in the final weeks, with practice exams and review sessions. Students who clear CPC during or right after the course move directly into senior coder roles. *Q: Can I do medical coding from home?* A: Yes. Medical coding is one of the most remote-friendly clinical careers in India. Many coders work fully from home after demonstrating productivity in an office for 6–12 months, and certified coders frequently move to freelance models on platforms like AAPC's job board, Aviacode, or US-based contracting firms. Productivity benchmarks (claims coded per hour, accuracy rate) are objective, which makes remote work practical. *Q: What is the difference between ICD-10, CPT, and HCPCS?* A: ICD-10-CM codes diseases and conditions (the 'why' of a healthcare encounter). CPT codes procedures and services performed (the 'what' physicians did). HCPCS Level II codes supplies, drugs, and services not in CPT (e.g., DME, ambulance, J-codes for injectable drugs). A typical claim uses all three: ICD-10 for diagnosis, CPT for the procedure, and HCPCS for any supplies or drugs administered. *Q: Who hires medical coders in Pune?* A: Pune has a strong medical coding employer base: Cognizant, Wipro, Optum, Sutherland, Omega Healthcare, Conduent, Genpact, and several mid-sized BPOs operating revenue cycle management for US clients. Hospital chains like Ruby Hall, Jehangir, and Manipal also hire smaller in-house teams. Most students place in MNC RCM operations within 60 days of CPC certification. *Q: Is medical coding difficult to learn?* A: Medical coding requires attention to detail, comfort with reading medical documentation, and patience with complex coding rules — but it does not require a medical degree. Life-sciences graduates with strong English typically do well. The 3-month course builds the anatomy and terminology foundation, then layers ICD-10/CPT/HCPCS systematically. The biggest hurdle for most students is initially memorising coding conventions; this gets easier with daily practice. ### Course narrative ## Why medical coding is the fastest path into a healthcare career Medical coding is the most accessible entry point into the healthcare industry for life-sciences graduates in India. It requires no laboratory work, no fieldwork, no advanced degree — just a graduate qualification, strong English, and three months of structured training. It is also one of the most remote-friendly careers in pharma or healthcare. Once you have CPC certification and 6–12 months of demonstrable productivity, fully remote roles are standard, and freelance/contract work on US-based platforms is a clear pathway to higher income for those who want it. For B.Pharm, B.Sc, and graduates in non-metro cities — or anyone seeking a career that can be done from home — medical coding offers a rare combination: high demand, fast time-to-employment, and genuine remote flexibility. ## What does a medical coder actually do The work is precise and document-driven. Every healthcare encounter — a hospital visit, an emergency department admission, a surgery, a routine office visit — produces clinical documentation. Your job is to translate that documentation into standardised codes that insurers and payers use to process claims. A typical day involves: - Reading physician notes, operative reports, and discharge summaries - Assigning ICD-10-CM codes for diagnoses - Assigning CPT codes for procedures and E/M services - Assigning HCPCS Level II codes for supplies, drugs, and DME - Applying modifiers correctly to communicate the nuances of the encounter - Flagging documentation gaps (CDI work) when codes cannot be defended - Meeting daily productivity targets (typically 12–25 charts/hour depending on complexity) and accuracy benchmarks (95%+) The work is heavily process-driven, scales with experience, and rewards coders who specialise (ED, surgery, risk adjustment, denials). ## The Pune medical coding market in 2026 Pune is one of India's top three medical coding hubs (alongside Chennai and Hyderabad), driven by a dense MNC RCM presence: - **Cognizant** — large coding operations across multiple Pune locations - **Wipro** — RCM division with strong CPC-certified coder hiring - **Optum** (UnitedHealth Group) — hires hundreds of CPC-certified coders annually - **Omega Healthcare** — coding-only specialty BPO with major Pune operations - **Sutherland Healthcare** — RCM and coding workflows - **Access Healthcare, Conduent, Genpact** — diversified RCM employers Salaries scale fast: an entry coder at ₹3–3.6 LPA pre-CPC moves to ₹4.5–5 LPA within 12 months of certification, and senior coders or auditors at 4+ years earn ₹6.5–8.5 LPA. Risk Adjustment / HCC coders earn the highest in the field due to ongoing US payer demand. ## What this course teaches The 3-month curriculum is dense and exam-focused. The first 4 weeks build your **anatomy, medical terminology, and pharmacology foundation** — non-medical graduates need this; medical and dental graduates can move faster. The middle 6 weeks cover **ICD-10-CM, CPT, and HCPCS Level II** systematically. You code real anonymised cases by body system and procedure category, work through E/M coding scenarios with the 2021/2023 updates, and practice modifier usage on surgery cases. The final 2 weeks shift to **AAPC CPC exam preparation**. You write multiple full-length practice exams under timed conditions, review weak areas, and learn the exam-specific time management that makes CPC clearable on the first attempt. Throughout the course you build a **portfolio of coded cases** — ED, surgery, inpatient, outpatient, risk adjustment — that you can show interviewers as proof of skill, which is unusual for fresh coding graduates. ## What makes this medical coding course different Most medical coding courses in India are either too academic (hours of slide decks with no real coding practice) or too rushed (boot camps that race through the manuals without building real understanding). We rebuilt the curriculum around how Pune RCM employers actually hire and onboard coders. Our faculty includes: - A **CPC-certified coder with 8 years of experience** who teaches ICD-10 and E/M coding from real adjudicated cases - A **coding auditor** at a large Pune MNC who teaches modifier usage and quality review - An **AAPC-approved instructor** for CPC exam prep, with a 90%+ first-attempt pass rate among prepared students These instructors teach from production cases, not textbook examples. ## Placement and CPC certification support Medical coding hiring is skills-tested at almost every employer — you will sit a 30–60 minute live coding test as part of the interview. Our placement preparation directly addresses this: **CPC exam strategy.** The course includes 5 full-length CPC practice exams with proctored conditions and detailed feedback. Students who follow the prep schedule clear CPC at high rates. **Live coding interview practice.** Three rounds of timed coding tests on real ED, outpatient surgery, and E/M cases — exactly the format used at Cognizant, Optum, and Omega Healthcare interviews. **Resume calibration.** We rewrite resumes to surface CPC status, body-system specialisation interest, and your portfolio of coded cases. **Direct introductions.** Our placement team works with 20+ Pune RCM employers. Top performers — particularly those who clear CPC during the course — are introduced directly to coding managers, often skipping initial screening rounds. ## Remote and freelance pathways For students whose long-term goal is fully remote or freelance work, we cover the practical setup in the final week: - AAPC member portal navigation and job board access - Building a profile on Aviacode and similar coder platforms - US contracting firm shortlist (often the highest-paying remote work) - Productivity benchmarks for credibility (charts/hour, accuracy) - Tax and contracting basics for Indian freelance coders working US clients Most students start in an MNC office for 12–18 months to build production credentials, then transition to remote or freelance — but the option is there from day one for the right candidates. ## Apply for the next batch Medical coding batches start monthly at our Wakad campus, with batch sizes capped at 30 students for adequate hands-on coding practice and CPC exam prep attention. Reach out on WhatsApp to discuss your background and intake batch availability. --- ## Medical Writing Course in Pune **URL:** https://ilearncri.com/courses/medical-writing/ **Duration:** 4 months **Mode:** classroom **Fees:** ₹66,000 (₹0.7 lakh) **Summary:** iLearn CRI's 4-month Medical Writing course in Pune covers protocols, CSRs, manuscripts, regulatory submissions, and publication writing — taught by practicing medical writers with placement support. **Eligibility:** - B.Pharm, M.Pharm graduates - B.Sc / M.Sc in Life Sciences, Biotechnology, Microbiology - BDS, BHMS, BAMS, BPT graduates - MBBS graduates with research interest - Strong English language skills required (writing test at admission) **Syllabus:** - **Foundations of Medical Writing:** Medical writing landscape: regulatory, scientific, promotional, educational; Stakeholders: sponsor, CRO, journals, regulators; Career pathways: regulatory writer, scientific writer, publication specialist; Indian and global medical writing market in 2026; ICMJE, GPP3, and authorship ethics - **Scientific Communication Fundamentals:** IMRaD structure for scientific manuscripts; Active voice, sentence-level clarity, plain language principles; Statistical reporting standards; Tables, figures, and visual abstracts; Editing and self-review checklists - **Regulatory Medical Writing:** Clinical Study Report (CSR) — ICH E3 structure, hands-on writing; Clinical Trial Protocol writing — SPIRIT guidance; Investigator's Brochure (IB) — ICH E6; Patient Narratives for SAEs; Common Technical Document (CTD) modules; Plain-language summaries for trial transparency - **Manuscript & Publication Writing:** Targeting journals — impact, scope, audience; Cover letters and submission strategy; Peer review response letters; Conference abstracts and posters; Editorial guidelines: ICMJE, EQUATOR Network (CONSORT, STROBE, PRISMA); Plagiarism and AI-content detection - **Pharmacovigilance & Safety Writing:** DSUR (Development Safety Update Report); PSUR / PBRER structure; Risk Management Plans; Signal evaluation reports; MedDRA terminology in narrative writing - **Medical Communications & Promotional Writing:** MSL slide decks and detail aids; CME content and educational modules; Promotional review (OPDP, MHRA Blue Guide considerations); Patient education materials; Medical writing for digital channels - **Tools & Workflow:** MS Word advanced: styles, cross-references, tables of contents; Reference managers (EndNote, Mendeley, Zotero); PleaseReview, Veeva Vault Quality Docs overview; AI-assisted writing — appropriate use and disclosure; Project management for writers (timelines, version control) - **Career Preparation & Placements:** Building a writing portfolio; Resume and cover letter for medical writer roles; Sample editing tests (the universal interview format); Mock interviews with practicing medical writers; Direct hiring partner introductions **Career outcomes:** - Medical Writer (Trainee): ₹ 3.6–4.5 LPA - Associate Medical Writer: ₹ 4.5–6.5 LPA - Regulatory Medical Writer: ₹ 5.5–8.0 LPA - Publication / Manuscript Writer: ₹ 5.0–7.5 LPA - Senior Medical Writer (3-5 yrs): ₹ 9.0–14.0 LPA - Freelance Medical Writer: ₹ 6.0–18.0 LPA (variable) **Frequently asked questions:** *Q: Is medical writing a good career after B.Pharm?* A: Medical writing is one of the most intellectually rewarding entry paths into pharma for B.Pharm graduates with strong writing skills. It pays competitively (₹3.6–4.5 LPA at entry, scaling to ₹9–14 LPA at senior level), is largely office-based with no field travel, and increasingly offers remote and freelance flexibility. The ceiling is high — senior medical writers at large CROs cross ₹15 LPA, and freelance writers with publication track records often earn more than full-time peers. *Q: What is the difference between regulatory and scientific medical writing?* A: Regulatory medical writing produces documents required by regulatory authorities — Clinical Study Reports, Trial Protocols, Investigator's Brochures, CTD modules, periodic safety reports. The format is highly prescribed and the audience is regulators. Scientific (publication) writing produces manuscripts, abstracts, and review articles for peer-reviewed journals — the format is journal-specific and the audience is the scientific community. Most senior medical writers do both; many specialise in one as they advance. *Q: Do I need to be a doctor to be a medical writer?* A: No. Most medical writers in India are B.Pharm or M.Pharm graduates, with M.Sc Life Sciences and BDS graduates well represented. MBBS doctors do enter the field — typically into medical communications or senior CSR roles — but the majority of working medical writers are non-MD pharmacists and life-scientists. What matters is precise writing, comfort with statistical reporting, and the ability to read primary research. *Q: How important is the writing test in admission?* A: Critical. Medical writing requires a baseline level of written English that cannot be taught in a 4-month course — it has to be built into your education before you start. The admission writing test screens for grammar, sentence-level clarity, and ability to summarise complex content. Students who do not pass this test are redirected to other course options, even if they want medical writing. This protects both you and the cohort. *Q: Will I write for journals during the course?* A: Yes. The course includes a structured manuscript-writing module where you work on a publishable manuscript with faculty guidance. Top students often submit and publish in indexed journals — a publication on your resume changes your interview trajectory dramatically. You will also write protocol sections, CSR sections, patient narratives, and a sample DSUR — building a portfolio you can show interviewers. *Q: Who hires medical writers in Pune?* A: Pune's medical writing employers include Syngene International, Veeda Clinical Research, Lambda Therapeutic Research, ICON, IQVIA, Parexel, Cipla, Sun Pharma, Lupin, and several mid-sized medical communications agencies. The freelance market is also strong — Pune-based writers regularly contract with US, UK, and European pharma sponsors. Most placements are at CRO regulatory writing teams or sponsor-side medical affairs. ### Course narrative ## Why medical writing is one of the highest-leverage careers in pharma Medical writing is the discipline of turning clinical evidence into the documents that move drugs through approval and into prescriber hands. It is precise, intellectually demanding work — and for graduates with strong writing skills, one of the most rewarding career paths in the entire pharma value chain. The demand is structural. Every clinical trial generates 50–200 documents that need writing or revision: protocols, investigator's brochures, study reports, safety updates, patient narratives, manuscripts, conference abstracts. India's CRO sector now writes a significant share of these documents for global sponsors, and Indian medical writing teams are growing 15–20% year over year. For B.Pharm, M.Pharm, B.Sc Life Sciences, BDS, and MBBS graduates with strong English, medical writing offers the best combination of intellectual depth, office-based work, remote flexibility, and long-term compensation growth in pharma. ## What does a medical writer actually do The work depends on which side of medical writing you choose, but most early-career writers do a mix: **Regulatory writing** — drafting and revising the documents that go to regulatory authorities. The Clinical Study Report (CSR) is the centrepiece of every Phase II/III trial; protocols, investigator's brochures, and patient narratives are constant work. The format is heavily templated (ICH E3, ICH E6, CTD modules), but interpreting trial data and writing it precisely is the skill. **Manuscript and publication writing** — drafting journal articles, conference abstracts, posters, and review articles. You work with academic and industry investigators to turn raw data into publishable science, then navigate the peer review process. **Pharmacovigilance writing** — DSURs, PSURs/PBRERs, Risk Management Plans, and signal evaluation reports. Heavily structured, with strict timelines and regulatory consequences for errors. **Medical communications** — slide decks for medical science liaisons, CME content, patient education materials, and promotional documents (under strict OPDP/MHRA review). Day-to-day, you read primary research, draft and revise documents, incorporate reviewer feedback, manage version control, and meet timelines that are often non-negotiable (regulatory deadlines do not slip). The work compounds — every CSR you write makes the next one faster. ## The Pune medical writing market in 2026 Pune is a strong medical writing hub, second to Bangalore among Indian cities. Major employers: - **Syngene International** — large medical writing team supporting Bristol Myers Squibb, Baxter, and other sponsor accounts - **Veeda Clinical Research** — generics and biosimilars regulatory writing - **Lambda Therapeutic Research** — bioequivalence and Phase I writing - **ICON, IQVIA, Parexel** — global CRO India delivery centres with significant medical writing headcount - **Cipla, Sun Pharma, Lupin, Glenmark** — sponsor-side medical affairs and regulatory writing teams - **Mid-sized medical communications agencies** — focused on publications and MSL content Salaries scale predictably: ₹3.6–4.5 LPA at entry, ₹5.5–8 LPA at the regulatory writer level (2–4 years), ₹9–14 LPA at senior writer (3–5 years). Freelance writers with publication track records often outearn full-time senior peers. ## What this course teaches The 4-month curriculum is built around the actual deliverables a Pune medical writer produces in their first 18 months on the job. The first month builds **scientific communication fundamentals** — IMRaD, active voice, statistical reporting, EQUATOR network reporting standards (CONSORT, STROBE, PRISMA). Most students need this even if they think their writing is strong. Months two and three focus on **regulatory medical writing**. You write sections of a real CSR, draft a protocol synopsis, write patient narratives for sample SAEs, and produce sections of an investigator's brochure. By the end of month three, you have a portfolio of 6–10 substantial writing samples. Month four is **publication writing and pharmacovigilance writing**. You complete a manuscript draft (some students publish), write a sample DSUR section, and learn the editorial workflow for peer-reviewed submission. Throughout the course you use **MS Word at an advanced level** (styles, cross-references, table of contents, comment workflows) and learn at least one reference manager (EndNote or Zotero). The final week covers AI-assisted writing — when it helps, when it harms, and how to disclose appropriately. ## Why graduates choose this medical writing course Most medical writing courses in India are taught by academics, not practicing writers. The curriculum tends to be theoretical, the examples are dated, and students leave with no portfolio. We rebuilt the curriculum around how Pune CROs actually hire and onboard medical writers. Our faculty includes: - A **Senior Regulatory Writer** with 10+ years across IQVIA and Parexel, who teaches CSR writing from her actual completed reports - A **Publication Writer** with 30+ peer-reviewed manuscripts and a track record in oncology and cardiovascular trials - A **Pharmacovigilance Writer** specialising in DSUR/PBRER who teaches the safety writing modules These instructors do not lecture from textbooks. They teach from the actual reports they delivered last quarter, with real edits and reviewer comments visible. ## Admission writing test Medical writing is the only iLearn CRI course with a writing test at admission. We ask candidates to summarise a complex paper in 250 words, write a short response to an editorial prompt, and complete a grammar review. Students who do not pass are redirected to other course options. This is not gatekeeping — it is protection. A 4-month course cannot teach the level of written English medical writing requires. We want every admitted student to clear placements at strong CTCs, and that starts with selecting people who can build on the foundation we provide. ## Placement support for medical writer roles Medical writing hiring is portfolio-tested at almost every employer — you will sit a writing or editing test as part of every interview. Our placement preparation addresses this: **Portfolio.** By the end of the course you have 6–10 writing samples (CSR sections, protocol synopsis, patient narrative, manuscript draft, DSUR section). Most candidates from competing institutes have nothing to show. **Editing test prep.** Three rounds of timed editing tests on real CSR sections, manuscript drafts, and DSUR excerpts — exactly the format used at Syngene, IQVIA, and Parexel interviews. **Resume calibration.** We rewrite resumes to highlight document types, therapeutic areas, and any quantifiable writing or editing work — the exact signals medical writing managers screen for. **Direct introductions.** Our placement team works with 30+ medical writing employers in Pune. Top performers — particularly those who publish a manuscript during the course — are introduced directly to writing managers. ## Apply for the next batch Medical writing batches begin every quarter at our Wakad campus, with batch sizes capped at 20 students for the writing-intensive workshop format. Admission requires the writing test. Reach out on WhatsApp to discuss your background and the next intake batch. --- ## Regulatory Affairs Course in Pune **URL:** https://ilearncri.com/courses/regulatory-affairs/ **Duration:** 5 months **Mode:** classroom **Fees:** ₹84,000 (₹0.8 lakh) **Summary:** iLearn CRI's 5-month Regulatory Affairs course in Pune covers CDSCO, USFDA, EMA submissions, eCTD, drug approval pathways, post-marketing compliance — taught by practicing regulatory professionals with placement support. **Eligibility:** - B.Pharm, M.Pharm graduates - M.Sc Pharmaceutical Sciences, Biotechnology, Microbiology - BDS, BHMS, BAMS graduates - MBBS graduates seeking pharma transition - Working pharma professionals seeking regulatory specialisation **Syllabus:** - **Foundations of Regulatory Affairs:** Drug development lifecycle from a regulatory lens; Major regulatory authorities: CDSCO, USFDA, EMA, MHRA, PMDA, NMPA; Career pathways in regulatory affairs; Indian and global regulatory landscape in 2026; Regulatory intelligence — staying current with changing guidance - **Indian Regulatory Framework — CDSCO Deep Dive:** Drugs and Cosmetics Act, 1940 and key rules; New Drugs and Clinical Trials Rules, 2019; Schedule M, Schedule Y, Schedule D; CDSCO organisation: SUGAM portal, Form 44, Form 45; State drug controllers and zonal offices; Approval pathways: new drug, biosimilar, generic; Import licences (Form 10, Form 11, Form 12-AA) - **USFDA Regulatory Affairs:** FDA structure: CDER, CBER, CDRH, CFSAN; 21 CFR overview; IND, NDA, ANDA, BLA pathways; Pre-IND, end-of-Phase 2, Pre-NDA meetings; Orange Book and patent strategy; Hatch-Waxman and 505(b)(2) pathways; User fees: PDUFA, GDUFA, BsUFA; Inspections: PAI, GMP audits, FDA Form 483 - **European Regulatory Affairs:** EMA structure: CHMP, PRAC, CMDh; Marketing Authorisation Procedures: Centralised, Decentralised, MRP, National; EU Clinical Trials Regulation (CTR 536/2014); PSUSA and EU PV reporting; Variation procedures (Type IA, IB, II); MHRA post-Brexit divergence - **CTD & eCTD Submissions:** Common Technical Document (CTD) — Modules 1–5 in depth; Module 1: regional administrative information; Module 2: quality, nonclinical, clinical summaries; Modules 3–5: quality, nonclinical, clinical detail; eCTD lifecycle: initial submission, sequence numbering, validation; Tools: Lorenz docuBridge, ExtedoEURS, GlobalSubmit overview; Hands-on dossier compilation exercises - **Drug Master Files & Active Substance:** DMF types I–V (US perspective); ASMF (Active Substance Master File) — EU; CEP (Certificate of Suitability); DMF deficiency response strategies - **Post-Approval & Lifecycle Management:** Post-approval changes — variation classification; Annual reports and PADERs; Labelling and product information updates; Risk Evaluation and Mitigation Strategies (REMS); Pharmacovigilance regulatory interface; Renewal and re-registration - **Quality, GMP & Inspections:** ICH Q-series (Q7, Q8, Q9, Q10, Q11, Q12); GMP inspections: USFDA, EU GMP, Schedule M; Audit response and CAPA management; Form 483 and Warning Letter responses - **Career Preparation & Placements:** Resume preparation for regulatory roles; Mock interviews with practicing regulatory professionals; Pune pharma & regulatory consulting landscape; Direct hiring partner introductions **Career outcomes:** - Regulatory Affairs Associate (Trainee): ₹ 3.5–4.5 LPA - Regulatory Affairs Associate: ₹ 4.5–6.5 LPA - Regulatory Publishing Specialist (eCTD): ₹ 5.0–7.0 LPA - DMF Specialist: ₹ 6.0–8.5 LPA - Senior Regulatory Affairs (3-5 yrs): ₹ 9.0–14.0 LPA - Regulatory Affairs Manager (7+ yrs): ₹ 16.0–28.0 LPA **Frequently asked questions:** *Q: Is regulatory affairs a good career after B.Pharm?* A: Regulatory affairs is one of the most stable and well-paid career paths in pharma for B.Pharm graduates. It pays competitively (₹3.5–4.5 LPA at entry, scaling to ₹9–14 LPA at senior level), is heavily process-driven, and rewards specialisation deeply — an experienced eCTD publisher or DMF specialist commands strong premiums. The work also offers global mobility because regulatory frameworks (CTD, ICH guidelines) are largely harmonised internationally. *Q: What is the difference between CDSCO and USFDA regulations?* A: CDSCO (India) and USFDA (United States) regulate drug approval and marketing in their respective markets, but the frameworks differ. USFDA uses 21 CFR with structured pathways (IND, NDA, ANDA, BLA), an electronic submission requirement (eCTD), and detailed user-fee programs. CDSCO operates under the Drugs and Cosmetics Act and the New Drugs and Clinical Trials Rules 2019, uses the SUGAM portal for submissions, and has zonal offices that handle regional matters. Indian generics exporters must comply with both — and many Pune regulatory professionals work both systems daily. *Q: Will I learn eCTD in this course?* A: Yes. eCTD is the standard submission format for USFDA, EMA, MHRA, and many other authorities, and it is increasingly required for CDSCO submissions. The course includes hands-on dossier compilation exercises, sequence numbering, validation, and an overview of major eCTD tools (Lorenz docuBridge, GlobalSubmit). You will compile a sample Module 1 and walk through a complete dossier structure under instructor guidance. *Q: Can I do regulatory affairs alongside my current pharma job?* A: Yes. The course runs weekday evenings (6–9 PM) and full Saturdays, designed for working pharma professionals who want to specialise in regulatory without leaving their current role. Many of our placements are internal moves — production or QA professionals who upskill into regulatory roles within the same company at a higher CTC. *Q: Who hires regulatory affairs professionals in Pune?* A: Pune's regulatory affairs employer base is dense: Cipla, Sun Pharma, Lupin, Glenmark, Wockhardt, Mylan, Emcure, and several mid-sized generics exporters all have regulatory teams. CROs (Syngene, Veeda, Lambda, ICON) hire regulatory writers and consultants. Specialist regulatory consultancies (Lambda Therapeutic Research's RA division, smaller boutiques) also hire steadily. Pune is one of India's strongest cities for regulatory affairs careers, particularly for generics and biosimilars work. *Q: How is regulatory affairs different from medical writing?* A: Both involve writing, but the focus differs. Regulatory affairs is about strategy and submissions — choosing the right pathway, preparing the dossier, interacting with regulators, and managing the product lifecycle. Medical writing is about producing the clinical and scientific content within submissions (CSRs, protocols, patient narratives). Many regulatory professionals also write portions of their submissions, but the core skill is regulatory strategy, not just writing. Regulatory roles also pay slightly higher at the senior level due to the strategic responsibility. ### Course narrative ## Why regulatory affairs is one of the most stable careers in pharma Regulatory affairs is the discipline of getting drugs approved and keeping them on the market. It is the bridge between the science of drug development and the laws that govern its marketing — and for pharma graduates with patience for detail and a strategic mindset, it is one of the most stable and well-compensated career paths available. The demand is structural. Every drug a pharma company markets requires regulatory work for its entire commercial life: initial approval, post-approval changes, label updates, periodic safety updates, renewal, and eventually withdrawal. Indian generics exporters file thousands of ANDAs, DMFs, and dossiers every year, and Pune is at the centre of this ecosystem. For B.Pharm, M.Pharm, and life-sciences graduates, regulatory affairs offers steady demand, structured progression, deep specialisation pathways (eCTD publishing, DMF, CMC strategy), and a strong long-term compensation curve. ## What does a regulatory affairs professional actually do The work depends heavily on the company and product, but most early-career regulatory affairs roles involve a mix of: **Regulatory strategy.** Choosing the right approval pathway for a product (NDA vs ANDA vs 505(b)(2); centralised vs MRP in EU), assessing market entry timelines, and advising the development team on regulatory implications of formulation or trial design choices. **Dossier preparation.** Compiling Module 1 (regional administrative), reviewing Modules 2–5 (clinical, nonclinical, quality summaries and details), and ensuring the submission is complete, internally consistent, and meets format requirements (eCTD validation passes, no broken references, correct hyperlinks). **Authority interactions.** Drafting responses to deficiency letters, preparing for pre-submission meetings, managing variation submissions for post-approval changes, and shepherding the product through inspections. **Lifecycle management.** Once approved, products generate constant regulatory work — annual reports, label changes, manufacturing site additions, packaging updates. This is where most regulatory affairs professionals spend the bulk of their time. The work compounds. Every dossier you compile teaches you the patterns of the next one. Senior regulatory professionals (5+ years) operate strategically — choosing pathways, sequencing submissions across markets, defending positions in front of regulators. ## The Pune regulatory affairs market in 2026 Pune is one of India's strongest cities for regulatory affairs careers, particularly for generics, biosimilars, and CRO regulatory consulting. Major employers: - **Cipla** — large regulatory team handling US, EU, and emerging markets across 200+ products - **Sun Pharma** — significant Pune regulatory operations supporting global filings - **Lupin** — strong US generics regulatory team with active ANDA filings - **Glenmark** — diversified portfolio with active US and EU filings - **Wockhardt** — regulatory team focused on biosimilars and complex generics - **Mylan / Viatris** — large regulatory operations - **Emcure** — Pune-headquartered with major regulatory team - **Syngene, Veeda, Lambda** — CRO regulatory affairs and consulting services - **Specialist regulatory boutiques** — focused consulting practices Salaries scale predictably: ₹3.5–4.5 LPA at entry, ₹5–7 LPA in eCTD publishing roles, ₹6–8.5 LPA in DMF specialisation, ₹9–14 LPA at senior associate or specialist level (3–5 years), and ₹16–28 LPA at manager level (7+ years). ## What this course teaches The 5-month curriculum is built around how Pune regulatory affairs teams actually work, with the depth required to be productive from day one in an entry-level role. The first month builds **foundations and the Indian regulatory framework** — Drugs and Cosmetics Act, Schedule Y, the New Drugs and Clinical Trials Rules 2019, CDSCO organisation and SUGAM portal, and the practical workflow for an Indian generics filing. Months two and three cover **USFDA and European regulatory affairs** in depth — IND/NDA/ANDA pathways, EMA centralised vs decentralised procedures, EU Clinical Trials Regulation, MHRA post-Brexit changes, and the strategic differences that drive market-by-market decisions. Month four is **CTD and eCTD submissions** — the heart of regulatory work. You compile sections of a sample dossier, learn the lifecycle of submissions (initial, supplements, variations), get hands-on with Module 1 preparation, and use industry tools like Lorenz docuBridge or GlobalSubmit at an introductory level. Month five covers **post-approval lifecycle management, GMP and inspections, ICH Q-series quality framework, and intensive placement preparation**. You walk through Form 483 response strategies, draft a sample variation submission, and complete the regulatory portion of a sample DMF. ## Why graduates choose this regulatory affairs course Most regulatory affairs courses in India are taught by academics with limited active regulatory practice. The curriculum tends to lag current regulations (especially EU CTR and US user-fee changes), and students leave without knowing how a real eCTD submission is built. We rebuilt the curriculum around how Pune regulatory teams actually work. Our faculty includes: - A **Senior Regulatory Affairs Manager** with 12+ years of US and EU generics filings, who teaches the dossier compilation and strategy modules - A **Regulatory Publishing Specialist** with 5+ years on eCTD tools (Lorenz, GlobalSubmit) at a top-10 Pune generics company - A **CDSCO regulatory consultant** with active SUGAM filings and pre-submission meeting experience These instructors teach from current submissions and live regulatory issues — not from textbook examples that are 5–10 years out of date. ## Placement support for regulatory affairs roles Regulatory affairs hiring is technically tested at most employers — you will face questions about CTD module structure, recent regulatory updates, and pathway selection in interviews. Our placement preparation addresses this: **Resume calibration.** We rewrite resumes to surface specific submission types (ANDA, DMF, variation), regulatory tool exposure (eCTD platforms), and any quantifiable regulatory work — the exact signals regulatory hiring managers screen for. **Mock interviews with practicing regulatory professionals.** Three rounds: technical (CTD structure, pathway selection, current updates), scenario-based (deficiency response, strategic choice questions), and behavioural. Every interview is conducted by a current regulatory professional at a Pune company. **Direct introductions.** Our placement team works with 30+ regulatory employers across Pune. Top performers — particularly those who can demonstrate familiarity with current submissions — are introduced directly to regulatory hiring managers. **Internal-move support.** Many of our students are existing pharma professionals (production, QA, formulation) seeking regulatory specialisation. We coach on the internal-transition conversation, including how to position the upskilling to your current employer for an internal move. ## Apply for the next batch Regulatory affairs batches begin every quarter at our Wakad campus, with batch sizes capped at 30 students for adequate hands-on dossier work. The course runs weekday evenings and Saturdays, designed to fit around current employment. Reach out on WhatsApp to discuss your background and the next intake batch. --- # Career guides & industry analysis ## AI in Pharmacovigilance 2026: What's Being Deployed, Which Roles Are Changing, and What Skills Now Matter **URL:** https://ilearncri.com/blog/ai-pharmacovigilance-2026/ **Author:** iLearn CRI Editorial **Published:** 2026-05-03 **Category:** pharmacovigilance **Summary:** Pfizer, Bayer, Novartis, and their outsourcing partners are deploying AI across ICSR triage, MedDRA coding, narrative drafting, and signal detection. Junior pharmacovigilance roles are not being eliminated, but they are being restructured. Here is what is actually happening and what it means for PV careers in India in 2026. **FAQs:** *Q: Is AI replacing pharmacovigilance jobs in India?* A: AI is not replacing pharmacovigilance jobs in India in 2026, but it is restructuring entry-level roles significantly. Tasks like initial ICSR triage, case data entry, and routine MedDRA term selection are being partially automated. However, AI-generated output requires human validation, case completeness assessment, causality evaluation, and regulatory submission decisions — all of which remain human responsibilities. The net effect is that junior PV professionals need different skills (AI output review, prompt construction for safety tools) rather than fewer jobs existing overall. *Q: Which AI tools are being used in pharmacovigilance?* A: Deployed tools include Oracle's AI-assisted ICSR processing within Argus Safety, IQVIA's Vigilance Detect platform for signal detection, Comprehend Medical (AWS) for adverse event extraction from narrative text, and proprietary LLM-based tools developed internally at Pfizer, Bayer, and Novartis for narrative drafting and case summarisation. MedDRA coding assistants from Saama Technologies and Cognizant Life Sciences are widely used at Indian CROs processing global caseloads. *Q: What new skills do pharmacovigilance professionals need in 2026?* A: Three skills stand out: first, the ability to validate AI-generated outputs (identifying errors in auto-coded MedDRA terms, inaccurate causality assessments, or missed seriousness criteria); second, working with safety-specific AI platforms like Oracle Argus AI, Veeva Vault Safety, and IQVIA Vigilance; third, understanding enough about how LLMs process clinical narratives to identify systematic failure modes. Prompt engineering for safety contexts — knowing how to instruct an AI tool to process a complex case accurately — is becoming a real differentiator at the senior associate level. *Q: Are Pune CROs using AI in pharmacovigilance operations?* A: Several Pune CROs are actively deploying AI tools in their PV operations. Syngene has integrated AI-assisted case processing for select global accounts. Lambda and Veeda are piloting automated ICSR triage tools. Sciformix (now part of Covance/Labcorp) runs AI-assisted narrative generation for ICSR volumes from US clients. The adoption pace is faster at CROs handling large global caseloads than at domestic pharma companies. *Q: What PV roles are growing despite AI automation?* A: Roles growing in this environment include: Signal Detection Analyst (AI generates signals; humans evaluate clinical relevance), Aggregate Safety Report Specialist (PSURs and PBRERs require medical and regulatory judgement), PV Quality Auditor (someone has to audit the AI output pipelines), and PV System Administrator roles (configuring and maintaining AI-integrated safety platforms). At the senior level, Drug Safety Physician and Medical Reviewer roles are unaffected and in demand. Three years ago, the discussion around AI and pharmacovigilance was largely theoretical. In 2026, the deployment is real. Pfizer's global safety operations use machine learning for ICSR prioritisation. Bayer's PV team published a case study on NLP-assisted case processing. Novartis has integrated AI-driven signal detection into its global safety monitoring programme. The Indian CRO industry, which processes a large share of global ICSR volume, is following the same trajectory. For pharmacovigilance professionals in India, the question is no longer whether AI will affect the field but how the role is changing, which skills are now required, and which career tracks will be stronger or weaker over the next five years. The picture is more nuanced than either "AI will take all PV jobs" or "nothing will change." ## What AI is actually doing in pharmacovigilance operations today AI applications in PV have concentrated in three areas: case intake and triage, MedDRA coding assistance, and signal detection. A fourth area, aggregate report generation, is earlier in deployment. ### ICSR triage and case processing The highest-volume, most repetitive task in pharmacovigilance is initial ICSR intake: receiving a case, assessing whether it meets minimum criteria (valid reporter, identifiable patient, suspected product, adverse event), classifying seriousness, assigning priority, and routing it for medical review. Pfizer deployed a machine learning-based triage system across its global safety database that classifies incoming ICSRs by seriousness and priority before a human reviewer touches the case. The system reduces the time a human medical reviewer spends on case intake by approximately 40%, based on figures Pfizer shared in its 2023 industry publication. Reviewers handle the cases the model has already triaged; their time goes into evaluation rather than intake. Oracle's Argus Safety platform, used across the majority of large pharma safety databases globally, now includes AI-assisted features for case processing. These include automated population of structured data fields from narrative text and suggested MedDRA coding terms based on adverse event descriptions. CROs running global caseloads through Argus are beginning to use these features, though adoption rates vary. Bayer's pharmacovigilance operations have used NLP-based systems to extract adverse event data from unstructured sources, including social media and patient forums, at a scale that would be operationally impossible with manual review. Bayer has been public about this through conference presentations at DIA and ISPE meetings. ### MedDRA coding assistance MedDRA coding, the translation of an adverse event description into a standardised term in the Medical Dictionary for Regulatory Activities hierarchy, has historically required trained human coders applying their judgement to ambiguous language. AI coding assistants now suggest the most appropriate MedDRA Preferred Term given the input language, with confidence scores and alternative term suggestions. Tools from Saama Technologies, Cognizant Life Sciences, and the AI layers within Veeva Vault Safety are widely used at Indian CROs processing global caseloads for US and EU clients. The human coder's role shifts from performing the initial code selection to reviewing and approving or correcting the AI's suggestion. The error profile of AI coding assistants is specific and learnable. They perform reliably on common adverse events with standard terminology, and less reliably on unusual presentations, multi-system events, or adverse events described in non-standard clinical language. A PV professional who understands where the AI makes systematic errors can catch those errors efficiently; one who treats AI output as essentially correct will miss a predictable class of mistakes. ### Signal detection Signal detection, identifying unexpected patterns in safety data that might indicate a new or changed risk, has always been constrained by the volume of data a human analyst can feasibly review. IQVIA's Vigilance Detect platform uses statistical algorithms and ML models to identify disproportionality signals across large safety databases, including the FDA's FAERS, WHO's VigiBase, and sponsor proprietary databases. Novartis has integrated AI-assisted signal detection into its safety monitoring programme, using it to prioritise signals for human review rather than relying solely on traditional disproportionality analysis. This does not reduce the need for trained signal detection analysts; it changes what they spend their time doing, from running statistical queries to evaluating the clinical significance of AI-surfaced signals. At Indian CROs, signal detection work is concentrated in specialist teams. The AI tools are largely running at the sponsor level, with CRO teams involved in data preparation and preliminary analysis. But as CROs grow their signal detection capabilities for smaller clients, the same pattern will appear domestically. ### Aggregate report generation PSURs, PBRERs, and RMPs require structured clinical writing, regulatory knowledge, and medical judgement. AI-assisted drafting tools are now producing first-draft sections for routine periodic safety reports, with human safety writers reviewing and editing. This is the area where AI application is most recent and where quality concerns are highest. The consequences of an error in a PSUR section submitted to EMA or USFDA are significant, and regulatory agencies have begun asking questions about AI involvement in submitted documents. The human safety writer role is not at risk, but the expectation of AI literacy in drafting workflows is growing. ## How junior PV roles are actually changing The entry-level pharmacovigilance role of 2022, one focused primarily on case intake, data entry, and routine MedDRA coding, is being restructured. The tasks most amenable to automation are precisely those that junior associates spent the most time on. The change is not that junior roles are disappearing. Global ICSR volumes are growing, driven by post-marketing surveillance obligations, digital adverse event reporting channels, and expanded pharmacovigilance requirements in markets like India, China, and Brazil. More cases exist to be processed. The change is that the human value-add at junior level is shifting from execution to verification. A junior PV associate in 2026 at a CRO using AI-assisted tools spends less time entering structured data and selecting MedDRA terms from scratch, and more time reviewing AI-generated outputs for accuracy, completeness, and compliance with regulatory definitions. The skills required are different: critical assessment of AI outputs, understanding of systematic AI failure modes, and enough regulatory knowledge to catch errors that the system makes with apparent confidence. Junior associates who treat this verification task casually, approving AI outputs without genuinely reviewing them, are both creating compliance risk for their employers and failing to develop the clinical judgement that separates senior PV professionals from junior ones. ## What new skills matter most ### AI output validation The foundational new skill for PV professionals at every level is the ability to critically assess AI-generated outputs. For ICSR processing, this means: - Knowing the regulatory definitions of seriousness, expectedness, and causality well enough to catch errors in AI classification - Understanding MedDRA hierarchy (SOC, HLGT, HLT, PT, LLT) well enough to identify when an AI-suggested term is technically plausible but clinically inaccurate - Recognising narrative extraction errors, where an AI has pulled the wrong adverse event from a complex case narrative This is fundamentally a domain knowledge task, not a technology task. The professionals best positioned to validate AI outputs are those with the strongest grounding in PV fundamentals. ### Platform familiarity with AI-integrated safety systems Oracle Argus Safety, Veeva Vault Safety, IQVIA Vigilance, and Saama's SMART Signals platform all have AI-assisted features that are now standard at global CROs. Knowing how these features work, not just how to navigate the case screen but how the AI assistance is integrated and where its outputs appear in the workflow, is a practical requirement for CRO employment. ### Signal evaluation and clinical reasoning As AI tools surface more candidate signals for review, the bottleneck shifts to clinical evaluation. A signal detection analyst needs to assess whether a statistical signal represents a real clinical risk, a confounded observation, or a data artefact. This requires pharmacology knowledge, epidemiological reasoning, and familiarity with the therapeutic area. These are skills that cannot be automated. ### Regulatory writing with AI-assisted tools For PV professionals moving into aggregate report writing, understanding how to use AI drafting tools effectively, how to prompt them usefully, how to edit their outputs efficiently, and how to identify the specific categories of error they produce in regulatory writing contexts, is now a practical skill. ## Which PV career tracks are at risk and which are growing | PV role | AI impact | Outlook | |---|---|---| | Junior ICSR Associate (data entry, coding) | High — task profile changing significantly | Stable volume, restructured role | | Senior Case Processor / Medical Reviewer | Moderate — AI handles intake, human handles evaluation | Stable, growing demand | | Signal Detection Analyst | Moderate — AI surfaces signals, humans evaluate | Growing, especially for specialists | | Aggregate Report Specialist (PSUR/PBRER) | Low-moderate — AI assists drafting | Stable to growing | | PV Quality Auditor | Low — AI creates audit demand | Growing | | PV System Administrator | Low — AI integration creates system roles | Growing | | Drug Safety Physician / Medical Officer | Very low — regulatory and medical judgement | Growing, shortage in India | | PV Regulatory Affairs (RMP, variation) | Low | Stable | The roles with the weakest outlook are those where the core task is literal data entry and routine code selection with no clinical judgement component. These existed at scale at Indian CROs that process high volumes of routine cases; those specific task profiles will shrink. The roles that are growing require either clinical/medical knowledge (Drug Safety Physician, Senior Medical Reviewer, Signal Detection Analyst) or technology system expertise (PV System Administrator, AI output quality auditor). The middle of the career ladder, Senior PV Associate through PV Manager level, remains robust because this is where clinical judgement and regulatory knowledge intersect. ## What Pune's CRO ecosystem is doing Pune's pharmacovigilance operations are concentrated at Syngene's global safety centre, Lambda Therapeutic Research's PV division, Veeda Clinical Research, Sciformix (part of Labcorp), and the PV units of pharma companies including Cipla, Lupin, Wockhardt, and Glenmark. Syngene has integrated AI-assisted case processing for its major global accounts, using tools within Oracle Argus Safety's AI feature set and a custom NLP layer for unstructured case data. Lambda and Veeda are in pilot phases with automated triage tools. The domestic pharma companies (Cipla, Lupin, Glenmark, Wockhardt) are at an earlier stage of AI integration in their PV operations, primarily because their India-centric case volumes have a different profile than the high-volume global caseloads that most benefit from AI triage. Adoption will accelerate as AI tools become standard in Argus and Veeva Vault Safety configurations. The practical implication for Pune-based PV job seekers: familiarity with Oracle Argus Safety (including its AI-assisted features), Veeda Vault Safety, and MedDRA coding assistants will differentiate candidates at CRO interviews. Employers running global caseloads are already using these tools and prefer candidates who understand them. ## The training consequence The pharmacovigilance training curriculum that adequately prepared a junior PV associate in 2022 does not fully prepare one for 2026. The additional requirements are: 1. Hands-on exposure to AI-assisted case processing workflows, even if only in training simulations 2. A thorough grounding in MedDRA fundamentals deep enough to validate AI term selections rather than just apply them 3. Understanding of seriousness, expectedness, and causality criteria precise enough to catch AI classification errors 4. Basic familiarity with how LLMs process clinical text, specifically the failure modes relevant to adverse event narratives iLearn CRI's [Pharmacovigilance programme](/courses/pharmacovigilance/) incorporates AI-integrated workflow training alongside the foundational ICH E2 series, MedDRA, and Argus Safety coverage that has always been core to the curriculum. The goal is not to train PV professionals to build AI systems, but to train them to work effectively and critically alongside the AI tools that are already standard in Pune's CRO operations. The analogy to draw is from clinical data management 10 years ago, when CDM professionals had to adapt from paper CRFs to EDC platforms. The ones who adapted fast became more valuable; the ones who resisted found themselves working on smaller and smaller legacy projects. AI in pharmacovigilance is that same transition, and it is already underway. For a deeper look at how the CRA and PV career tracks compare in terms of trajectory, skills, and temperament fit, see our [comparison of pharmacovigilance and CRA careers](/blog/pharmacovigilance-vs-cra/). For current salary benchmarks across both tracks, the [CRA salary breakdown for India 2026](/blog/cra-salary-india-2026/) covers the numbers in detail. --- ## ICH E6(R3) in India: What Changed, What CDSCO Has Done, and What Clinical Research Professionals Must Know **URL:** https://ilearncri.com/blog/ich-e6-r3-india-2026/ **Author:** iLearn CRI Editorial **Published:** 2026-05-03 **Category:** clinical-research **Summary:** ICH E6(R3) was finalised in May 2023 and adopted in 2024, overhauling three decades of GCP guidance with risk-based quality management, decentralised trial provisions, and modernised informed consent. India's regulatory alignment with this revision is partial and evolving. Here is what the changes mean in practice. **FAQs:** *Q: What is ICH E6(R3) and when did it come into effect?* A: ICH E6(R3) is the third revision of the International Council for Harmonisation's Good Clinical Practice guideline. The final guideline was adopted by the ICH Assembly in May 2023 and formally implemented by ICH member regulators, including USFDA and EMA, through 2024. It replaces E6(R2) from 2016 and substantially restructures GCP around risk-based principles, digital systems, and decentralised trial modalities. *Q: Has India's CDSCO adopted ICH E6(R3)?* A: As of mid-2026, CDSCO has not issued a formal circular adopting E6(R3) as the binding national GCP standard. The New Drugs and Clinical Trials Rules 2019 remain the primary regulatory framework. However, CDSCO's draft GCP guidance documents circulated in 2025 incorporate several E6(R3) concepts, particularly risk-based monitoring and electronic records provisions. Sponsors conducting global trials in India are already applying E6(R3) standards operationally. *Q: What is the biggest practical change in E6(R3) for CRAs?* A: The biggest operational shift is the formalisation of Risk-Based Quality Management (RBQM). Under E6(R3), monitoring plans must be driven by a prospective risk assessment of critical data and processes, not a blanket on-site SDV schedule. CRAs at sponsors and CROs applying E6(R3) are spending more time on centralised data review, risk signal interpretation, and targeted on-site visits, and less time on 100% source data verification at routine sites. *Q: Do Indian CROs apply E6(R3) to domestic trials?* A: For domestic trials funded by Indian sponsors under CDSCO oversight, adherence to E6(R3) is not yet mandatory. CROs running global multi-regional trials in India for US or EU sponsors apply E6(R3) because the sponsor's protocol requires it. The practical result is that large CROs (IQVIA, ICON, Parexel, Syngene) are already E6(R3)-aligned internally, while smaller domestic-only CROs are still operating under earlier GCP frameworks. *Q: How should a CRA train for ICH E6(R3) in 2026?* A: Training should cover three areas: the conceptual shift from prescriptive GCP to risk-based GCP (RBQM theory and application), the practical tools used in centralised monitoring (statistical risk signals, CTMS dashboards, remote SDV platforms), and the updated provisions on electronic records, electronic informed consent, and decentralised trial modalities. Structured CRA programmes that have updated their curriculum to reflect E6(R3) are the most efficient path. The International Council for Harmonisation finalised ICH E6(R3) in May 2023, and regulators in the US, EU, and Japan implemented it through 2024. For clinical research professionals in India, this revision is the most consequential update to Good Clinical Practice in nearly three decades. Most Indian clinical research training programmes have not yet caught up with it. Most domestic CROs running India-only trials are still operating under older frameworks. And CDSCO's formal position remains in progress. That gap creates both a compliance risk and a career opportunity. Understanding exactly what changed, where India currently stands, and what CRAs and pharmacovigilance professionals need to do differently is the starting point for being genuinely ready for global trial work in 2026. ## Why E6(R3) exists: the limitations of the previous version ICH E6(R1) was published in 1996. It defined Good Clinical Practice for an era of paper records, physical site files, and in-person monitoring as the dominant quality assurance mechanism. ICH E6(R2), adopted in 2016, added an addendum addressing risk-based approaches and electronic records, but it layered these concepts onto the original text rather than restructuring the guideline around them. The result was a guidance document that described modern risk-based monitoring and electronic data systems in an addendum while the core text still assumed paper-based, on-site-verification-centric operations. Sponsors and CROs implementing RBQM had to reconcile practices that the addendum endorsed with language in the body that implied on-site SDV was standard. E6(R3) resolves this by rebuilding the guideline from the ground up. The structure is reorganised into core principles and modular annexes. RBQM is woven throughout the core text, not appended to it. The guideline explicitly accommodates decentralised clinical trials, electronic informed consent, remote monitoring, and the use of technology platforms in ways that the 1996 structure could never cleanly support. ## What actually changed in E6(R3) ### Risk-Based Quality Management is now the foundation, not an addendum The most significant structural change in E6(R3) is that Risk-Based Quality Management moves from addendum guidance to core principle. Under E6(R3), sponsors are required to implement a systematic Quality Management System (QMS) that identifies Critical to Quality (CtQ) factors for each trial, prospectively assesses risk to those factors, and designs monitoring plans proportionate to that risk. For CRAs, this has direct operational consequences. The 100% source data verification model that many CROs used as the default is explicitly de-emphasised. Monitoring plans under E6(R3) must justify the intensity of on-site review based on the risk profile of the trial, not apply a blanket standard. Centralised statistical monitoring, remote SDV, and targeted on-site visits for high-risk sites or data anomalies replace the old schedule-driven approach. ### Decentralised clinical trial provisions E6(R3) is the first ICH GCP revision to explicitly address Decentralised Clinical Trials (DCTs). The guideline includes provisions for: - Direct-to-patient drug shipment in appropriate trial designs - Remote consent processes, including electronic informed consent via validated digital platforms - Digital data collection using wearables, ePRO platforms, and mobile applications - Remote monitoring and investigator oversight in settings where participants are not physically at the trial site For CRAs, this means the monitoring role increasingly extends to remote data verification, patient-reported outcome platform oversight, and site coordinator training on digital tool compliance. The physical site visit is not eliminated, but its function changes to quality assurance of the overall site system rather than line-by-line source verification. ### Modernised informed consent provisions E6(R3) expands and modernises the informed consent framework in several ways. The guideline now explicitly permits: - Electronic informed consent (eIC) through validated digital platforms, where permitted by local regulation - Multimedia consent materials (video explanations, interactive digital presentations) as supplements to the written consent form - Remote consent where the investigator or delegate conducts the consent discussion via video call with appropriate documentation The core ethical requirements remain unchanged: consent must be voluntary, documented, and based on adequate information. The change is that the medium through which consent is obtained and documented is now explicitly flexible. ### Computerised systems and electronic records The treatment of computerised systems in E6(R3) is substantially more detailed than in E6(R2). Sponsors and CROs are required to: - Validate computerised systems used in trial conduct - Ensure data integrity across all electronic platforms - Maintain audit trails that allow reconstruction of the trial chronology - Address cybersecurity as part of system validation For clinical data management and CRA professionals, this means that system validation documentation, audit trail review, and electronic records management are GCP competencies, not just IT responsibilities. CRAs monitoring sites using EDC platforms need to understand how to assess audit trail integrity, not just how to enter and review data. ### Roles and responsibilities are more clearly separated E6(R3) tightens the definition of sponsor and investigator responsibilities, particularly around delegation. Sponsors cannot delegate trial design and risk management responsibilities to CROs. Investigators must personally oversee all activities at their site, with documented delegation to sub-investigators and trial coordinators. The guideline is explicit that delegation does not transfer regulatory responsibility. This has practical implications for monitoring. CRAs working on delegated trials need to verify not just protocol compliance but the adequacy of the delegation structure at each site. ## Where CDSCO stands: the current regulatory picture India's primary clinical trial framework remains the New Drugs and Clinical Trials Rules 2019 (NDCT Rules). These rules are broadly consistent with ICH E6(R2) principles but predate E6(R3). CDSCO has not issued a formal circular adopting E6(R3) as the binding national standard. In 2025, CDSCO circulated draft revisions to India's GCP Guidelines (originally published as Schedule Y and amended in the NDCT Rules) that incorporated several E6(R3) concepts. The draft language addressed risk-based monitoring, electronic records integrity, and remote consent modalities. These drafts were open for stakeholder comment, and as of mid-2026, a final revised GCP notification is expected but has not been issued. The practical consequence is a two-tier situation in India: **Global multi-regional trials** conducted in India for US or EU sponsors must comply with E6(R3) because the sponsor's protocol, monitoring plan, and audit expectations are built around it. CROs running these trials (IQVIA, ICON, Parexel, Syngene, Lambda) have already updated their SOPs and training accordingly. **India-only trials** under domestic sponsors regulated by CDSCO continue to operate under NDCT Rules and legacy GCP frameworks. These sponsors will need to adapt when CDSCO finalises its GCP revision, but as of today, strict E6(R3) compliance is not mandatory for this category. For clinical research professionals, this means that E6(R3) fluency is a prerequisite for working on global trials in India, and will increasingly become the standard for domestic trials as CDSCO aligns. ## The gap between Indian GCP practice and E6(R3) expectations Several specific practice gaps are common in India's clinical research ecosystem when measured against E6(R3): **Monitoring plan design.** Many Indian CROs still use monitoring plans that specify fixed on-site visit frequencies regardless of site risk profile. E6(R3) requires risk-stratified monitoring with documented rationale. CRAs trained under older models will need to understand how to interpret centralised monitoring signals and apply them to visit planning. **Centralised monitoring infrastructure.** E6(R3) assumes sponsors have centralised statistical monitoring capabilities. Many smaller Indian CROs and domestic sponsors have not yet invested in CTMS platforms with risk signal reporting. The gap between global CRO practice and domestic CRO practice on this is material. **Electronic informed consent.** eIC adoption in India is very early. Most sites still use paper consent processes, and the regulatory framework for eIC in India is not yet fully defined. E6(R3)'s flexibility around consent modalities will be realised in India more slowly than in the US and EU. **Quality Management System documentation.** E6(R3)'s QMS requirement means sponsors and CROs need documented, prospective risk assessment processes for each trial. This is well-established at global CROs with ISO-certified quality systems but less common at smaller domestic operators. ## What CRAs need to know to be future-ready For a CRA working in India today, or planning to enter the field, E6(R3) literacy is a concrete career differentiator. The following capabilities matter: **RBQM theory and application.** This means understanding how risk assessments are constructed for a trial, what Key Risk Indicators (KRIs) are, how centralised monitoring generates risk signals, and how to act on those signals during site oversight. CRAs who can read a CTMS risk dashboard and design a targeted monitoring visit based on it are more valuable than those who execute fixed monitoring schedules. **Remote monitoring competence.** Remote SDV, remote site file review, and oversight of site staff via video platform are now standard components of the monitoring toolkit. CRAs who have only conducted on-site monitoring face a real skills gap. **Electronic records and audit trail assessment.** Being able to verify that an EDC system's audit trail is intact, that ePRO data timestamps are consistent, and that electronic records meet the ALCOA+ standards (Attributable, Legible, Contemporaneous, Original, Accurate, Complete, Consistent, Enduring, Available) is now a core CRA competency under E6(R3). **Informed consent verification for digital modalities.** As eIC becomes more common, CRAs need to know how to verify consent documentation in digital platforms, including audit trails for consent conversations, version history for consent forms, and site-level procedures for participants with limited digital access. ## What pharmacovigilance professionals need to know E6(R3)'s most direct implications for pharmacovigilance professionals relate to adverse event reporting and data integrity requirements during trials. The guideline strengthens requirements for integrated safety data management across trial data sources, including data from remote patient monitoring tools, wearables, and ePRO platforms. PV professionals working on clinical trial safety need to understand how adverse event data flows from these digital sources, and how audit trail requirements apply to safety data. The decentralised trial provisions also mean that site-level adverse event identification may now come from sources other than investigator-reported encounters. PV teams need processes for integrating adverse event signals from ePRO data, remote monitoring alerts, and wearable device data into standard ICSR workflows. ## Training implications for 2026 The E6(R3) transition creates specific training requirements for clinical research professionals in India: 1. **Understanding the QMS and RBQM framework.** Not just as a regulatory concept but as a practical tool. CRAs need to read monitoring plans that are risk-stratified and understand why site visit decisions are being made the way they are. 2. **Hands-on CTMS exposure.** Platforms like Veeva Vault CTMS, Oracle Clinical One, and Medidata Rave have built-in risk signal dashboards. Training on these platforms, specifically on the centralised monitoring features, is increasingly prerequisite for global trial work. 3. **Electronic records compliance.** Understanding ALCOA+ principles as applied to EDC systems, ePRO platforms, and remote monitoring tools. 4. **Decentralised trial modalities.** Direct-to-patient logistics, remote site coordinator support, and digital consent documentation are operational areas that did not exist in most CRA training programmes before E6(R3). iLearn CRI's [Clinical Research Associate programme](/courses/clinical-research-associate-cra/) and [Pharmacovigilance programme](/courses/pharmacovigilance/) have been updated to incorporate E6(R3) principles, including RBQM, remote monitoring, and electronic records compliance, so graduates are calibrated to the standards that global trial sponsors and large CROs are already operating under. ## The career case for E6(R3) fluency Most Indian clinical research training programmes have not yet updated their curricula to reflect E6(R3). Most domestic-only CRO experience will not expose CRAs to RBQM, centralised monitoring, or decentralised trial modalities in the near term. This creates a genuine differentiator. CRAs and PV professionals who understand E6(R3) specifically, who can speak to RBQM concepts, KRI interpretation, and audit trail review in interviews, are better positioned for roles at global CROs and sponsor-side positions than those with equivalent experience under older frameworks. The guideline shift is permanent. CDSCO will align with E6(R3) when it finalises its GCP revision. Sponsors running global trials in India are already applying it. The professionals who build E6(R3) competence now, rather than waiting for formal regulatory mandate, will be the ones hired into senior monitoring and quality roles first. --- ## Pharmacovigilance vs CRA: A Detailed Comparison to Help You Choose **URL:** https://ilearncri.com/blog/pharmacovigilance-vs-cra/ **Author:** iLearn CRI Editorial **Published:** 2026-05-03 **Category:** comparisons **Summary:** Pharmacovigilance and Clinical Research Associate are the two most common entry points into clinical research in India, but they suit very different temperaments. This comparison covers salaries, daily work, travel demands, growth trajectories, and a decision framework to help you pick the right path. **FAQs:** *Q: Which pays more, pharmacovigilance or CRA?* A: CRA has a higher long-term salary ceiling. At entry level, the gap is modest: CRA Level I typically starts at Rs 4.2-5.5 LPA versus PV Associate at Rs 3.5-4.5 LPA. By the 5-year mark, a Senior CRA earns Rs 12-18 LPA while a Senior PV Associate earns Rs 9-13 LPA. At the 10-year mark, a Lead CRA or Clinical Project Manager can reach Rs 22-35 LPA; a PV Manager or Drug Safety Director with equivalent experience reaches Rs 18-28 LPA. Sponsor-side roles on both tracks pay significantly more than CRO-side. *Q: Is pharmacovigilance or CRA easier to break into?* A: Pharmacovigilance has a higher volume of entry-level openings in India and a shorter training timeline (6 months for both, but PV has more immediate job availability because ICSR processing demand is very high). CRA roles are more competitive at entry because the monitoring skill set takes longer to demonstrate in interviews. Both paths require structured training; PV places faster on average for fresh graduates. *Q: Does CRA involve a lot of travel?* A: Yes. A CRA in a site monitoring role typically travels 50-70% of the time, sometimes more during intensive monitoring phases of a trial. This means frequent travel to hospital sites across a geographic region, often overnight stays 2-3 nights per week. CRAs who prefer desk-based work find this unsustainable. The travel component is the primary reason some professionals choose PV over CRA despite CRA's higher salary ceiling. *Q: Can you switch from pharmacovigilance to CRA later?* A: A switch is possible but not seamless. PV experience demonstrates regulatory and safety knowledge that is valued by sponsors and CROs, but it does not substitute for site monitoring experience. A PV professional switching to CRA typically needs to go through a CRA training programme and is likely to enter at Level I or Level II depending on their years of experience. The switch is easier going from PV to clinical trial operations or regulatory affairs than directly to field CRA monitoring. *Q: Which career is more stable, PV or CRA?* A: Both are stable. Pharmacovigilance has the advantage of being a legal regulatory requirement — pharma companies cannot stop conducting PV regardless of the economic cycle — which gives it recession-resistance. CRA demand is tied to clinical trial volumes, which fluctuate with pharma R&D spending. In India, ICSR processing outsourcing to CROs has grown consistently, meaning PV headcount in Pune and Bengaluru has expanded steadily. CRA headcount growth is also consistent but more cyclical. Both pharmacovigilance and Clinical Research Associate are legitimate, well-compensated entry points into clinical research. The decision between them is not about which is objectively better. It is about which suits how you work, what kind of schedule you want, and which career trajectory appeals to you over a 10-year horizon. The problem with most comparisons of these two paths is that they are written to recruit rather than inform. This one is not. The goal is to give you the information you need to make a clear-headed decision based on your actual preferences and circumstances. ## What each role does, precisely ### What a pharmacovigilance associate actually does A pharmacovigilance (PV) associate processes drug safety data throughout a drug's lifecycle. The core work at entry level is ICSR (Individual Case Safety Report) processing: receiving reports of adverse events from healthcare professionals, patients, or literature sources; assessing whether the case meets minimum criteria for reporting; coding adverse events using MedDRA; writing or reviewing the case narrative; and submitting to regulatory databases within strict timelines. Day-to-day at a Pune CRO or pharma company PV department: - Process 8-15 ICSRs per day (volume depends on employer and therapeutic area) - Apply regulatory seriousness criteria (is this event serious? unexpected?) - Select appropriate MedDRA Preferred Terms for adverse event descriptions - Write structured case narratives in English following regulatory conventions - Meet submission deadlines (15 days for serious cases to EMA/USFDA, 7 days for certain expedited cases) - Work within safety database systems (Oracle Argus Safety, Veeva Vault Safety, ARISg) At mid-level, PV professionals move into aggregate reporting (PSURs, PBRERs, signal detection, RMP contributions), case quality review, and team coordination. At senior level, the work is primarily medical evaluation, regulatory submissions, and cross-functional safety governance. ### What a Clinical Research Associate actually does A CRA monitors clinical trial sites to ensure that trials are conducted in accordance with the approved protocol, ICH-GCP guidelines, and applicable regulations. The core task is site monitoring visits: travelling to the investigator site (usually a hospital or clinic), reviewing patient records against CRF data (Source Data Verification), checking the Investigator Site File for regulatory compliance, reviewing protocol deviations, and writing the monitoring visit report. Day-to-day for a CRA in Pune or travelling from Pune: - Drive or fly to a hospital site (may be within Maharashtra or other states) - Spend 6-8 hours at the site reviewing patient source documents against EDC entries - Meet with the site coordinator and principal investigator to resolve queries - Check that informed consent documentation is complete and correctly executed - Review investigational product accountability records - Write the monitoring visit report on the same evening or within 5 days - Manage protocol deviation follow-up and corrective action plans At mid-level, CRAs handle more complex protocols, mentor junior CRAs, run site selection and feasibility assessments, and may coordinate multi-site monitoring plans. At senior level, the role moves toward Lead CRA (overseeing a monitoring team across a large trial) or Clinical Project Manager (managing the full trial operationally). ## The fundamental difference in work character Pharmacovigilance is primarily an analytical, regulatory, and data-processing role. The work is systematic, schedule-driven, and desk-based. The cognitive demand is sustained attention to case detail, regulatory classification accuracy, and written communication precision. The environment is predictable. CRA monitoring is an operational field role. It involves constant context-switching, travel logistics, relationship management with site staff, and on-the-spot problem-solving at the site. The cognitive demand is adaptability, attention to documentation accuracy under time pressure, and professional communication with investigators who may be senior physicians. The environment varies by site. Neither description is superior. They suit fundamentally different professional temperaments. ## Eligibility: who can enter each path | Qualification | Pharmacovigilance | CRA | |---|---|---| | B.Pharm | Yes | Yes | | M.Pharm | Yes | Yes | | MBBS / BDS | Yes | Yes (preferred for oncology/specialty) | | B.Sc Life Sciences | Yes | Yes | | M.Sc Pharmacology / Biochemistry | Yes | Yes | | Nursing (B.Sc Nursing) | Yes | Yes (some sponsors) | | Non-science backgrounds | No | No | Both tracks are accessible to the same core qualifications. MBBS and BDS graduates are particularly valued in both tracks: in PV for medical evaluation and causality assessment; in CRA for building rapport with investigators and understanding complex protocols. The differential for MBBS/BDS is larger at CRO level in CRA, where physician CRAs are often tracked into senior monitoring roles faster. ## Training timeline comparison | Parameter | Pharmacovigilance | CRA | |---|---|---| | Programme length | 6 months | 6 months | | Core curriculum | ICH E2A-E2F, MedDRA, Argus Safety, signal detection basics, PSUR/PBRER | ICH E6 GCP, site monitoring procedures, SDV, EDC platforms, protocol review, monitoring report writing | | Certifications | DIA Pharmacovigilance Certificate | ICH-GCP TransCelerate or equivalent | | Hands-on training | Argus/ARISg case processing simulations, MedDRA coding exercises | Monitoring simulation visits, CRF/source document exercises, CTMS familiarisation | | Typical time to first job after training | 45-75 days | 60-90 days | The training timelines are broadly equivalent. PV training tends to result in faster placement because ICSR processing roles are higher volume at Pune CROs. CRA placement takes slightly longer because monitoring roles require a more demanding interview process (GCP knowledge testing, case study exercises, communication assessment). ## Salary comparison across career stages | Career stage | Pharmacovigilance | CRA | |---|---|---| | Entry (0-2 years) | Rs 3.5-4.5 LPA | Rs 4.2-5.5 LPA | | Mid (2-4 years) | Rs 6-9 LPA | Rs 7-11 LPA | | Senior (4-7 years) | Rs 9-13 LPA | Rs 12-18 LPA | | Lead/Manager (7+ years) | Rs 15-25 LPA | Rs 18-32 LPA | | Director/Head (10+ years) | Rs 25-40+ LPA | Rs 30-50+ LPA | The CRA advantage grows with experience. At entry level, the difference is modest, roughly Rs 70,000-1 LPA. By the 5-year mark, a Senior CRA earns 20-40% more than a Senior PV Associate at the same employer type. By 10 years, a Clinical Project Manager earns substantially more than a PV Manager, though the very top of the PV ladder (VP Drug Safety, Global Head of Pharmacovigilance at a large pharma) reaches compensation comparable to senior clinical development management. Sponsor-side roles on both tracks pay 15-25% more than CRO-side at equivalent experience levels. CRAs and PV professionals at Cipla, Sun Pharma, or Lupin typically earn more than counterparts at Lambda or Veeda with the same years of experience. For a detailed breakdown of CRA salary by level and city, see [CRA salary in India 2026](/blog/cra-salary-india-2026/). ## Travel requirements: the decisive factor for many This is where the two paths diverge most concretely. **Pharmacovigilance:** Entirely desk-based. Standard office hours, sometimes shift work (morning, evening, or night shifts) at CROs processing caseloads across global time zones. No travel to sites. Work from home arrangements are common for experienced PV professionals. PV roles are among the most remote-friendly in the pharma industry. **CRA:** 50-70% travel is the typical requirement. For a CRA covering a region like Maharashtra plus neighbouring states, this means 2-3 overnight stays per week during active monitoring phases, regular train and flight travel, and site visits that begin at 9 AM at a hospital 3-4 hours from home. During database lock periods, travel intensity spikes further. Some professionals find the CRA travel schedule energising: new cities, varied sites, direct patient contact context. Others find it incompatible with their personal circumstances (family responsibilities, health, preference for routine). This is not a judgement about which preference is correct. It is a practical reality that should drive the decision for many candidates. ## Work setting and daily rhythm | Factor | Pharmacovigilance | CRA | |---|---|---| | Primary location | Office or home office | Field (hospital sites) | | Travel | None | 50-70% | | Work hours | Defined shifts (sometimes rotating) | Variable, site-dependent | | Remote work | Common for experienced staff | Partial; remote SDV growing but on-site visits remain | | Work-life predictability | High | Moderate to low | | Team interaction | Daily with PV team, database team | Periodic with sponsor/CRO team; frequent with site staff | | Patient contact | Indirect (through reports) | Indirect (reviewing patient records at site) | ## Skills that compound your career in each path ### Pharmacovigilance skills that accelerate progression 1. **Medical writing proficiency.** The ability to write clear, complete, medically accurate ICSR narratives distinguishes fast-progressing PV associates from average ones. Companies notice narrative quality. 2. **MedDRA expertise.** Associates who understand MedDRA hierarchy deeply, specifically who can select the most clinically meaningful term rather than just the technically correct one, become quality reviewers and trainers faster. 3. **Signal detection methodology.** Disproportionality analysis (PRR, ROR, EBGM) is a career differentiator. Most entry-level PV training does not cover this; those who learn it independently are preferred for senior roles. 4. **Regulatory submission knowledge.** Understanding EMA, USFDA, and CDSCO submission formats, timelines, and requirements makes a PV professional cross-functional. 5. **Clinical therapeutic area depth.** PV professionals with deep knowledge of oncology, cardiovascular, or CNS pharmacology command significant salary premiums. ### CRA skills that accelerate progression 1. **Monitoring volume and site breadth.** CRAs who have monitored 30+ sites across 3+ therapeutic areas get promoted 12-18 months faster than those with narrow site exposure. 2. **Oncology or rare disease experience.** These TAs pay 20-30% more and open doors to global sponsors at every experience level. 3. **RBQM and centralised monitoring.** Risk-Based Quality Management skills are increasingly required under ICH E6(R3). CRAs who understand KRI interpretation and CTMS risk dashboards are differentiated. 4. **Protocol complexity.** CRAs who have worked on Phase I, first-in-human, or complex multi-arm trials are more valuable than those with Phase III generics experience only. 5. **Languages.** CRAs who speak Hindi plus 2 regional languages can cover a much larger site footprint, which makes them more deployable and more valuable to CROs. ## Long-term career trajectories Both paths offer genuine long-term careers, not just entry-level jobs. But they lead to different places. **Pharmacovigilance career ladder:** - PV Associate (0-2 years) - Senior PV Associate / Case Processor (2-4 years) - PV Team Lead / Quality Reviewer (4-6 years) - PV Manager / Signal Detection Specialist (6-9 years) - Drug Safety Manager / PV Head (India or regional) (9-12 years) - VP Drug Safety / Global Pharmacovigilance Head (12+ years) PV also opens lateral paths: Regulatory Affairs (medical writing and PSUR expertise transfers directly), Clinical Safety Writer, PV Consultant, PV System Administrator. The regulatory writing career track, specifically writing DSURs, PBRERs, and RMPs, is a well-compensated specialisation within PV. **CRA career ladder:** - CRA Level I (0-2 years) - CRA Level II (2-4 years) - Senior CRA / Lead Site Monitor (4-7 years) - Lead CRA / Clinical Trial Manager (7-10 years) - Clinical Project Manager (8-12 years) - Director Clinical Operations / VP Clinical Development (12+ years) CRAs can also pivot into clinical regulatory affairs, site management organisation (SMO) management, or training and quality roles. Clinical Project Managers with strong sponsor-side experience move into Global Study Directors and above. The PV track produces regulatory and safety experts; the CRA track produces trial operations generalists and eventually clinical programme managers. Both are needed in the industry. ## Comparing demand and job availability in Pune | Metric | Pharmacovigilance | CRA | |---|---|---| | Total annual openings in Pune (estimate, 2026) | 800-1,100 | 500-750 | | Entry-level fraction | ~60% | ~45% | | Primary employers | Cipla, Lupin, Syngene, Lambda, Sciformix, Wockhardt, Glenmark, Veeda | Syngene, Lambda, Veeda, IQVIA, ICON, Parexel, Reliance Life Sciences, Cipla, Sun Pharma | | Remote work available | Yes (partial to full) | Partial (remote SDV growing, on-site still dominant) | | Freelance/contract market | Growing (especially for PV writers and specialists) | Small but present (independent CRAs for SMOs) | PV has a higher volume of openings in Pune, partly because Pune's CRO ecosystem processes a large share of global ICSR volume for US and EU clients. The demand is structural and consistent. CRA openings are somewhat more competitive at entry because the total volume is lower and the interview process is more rigorous. However, a CRA with strong training and placement preparation from a reputable programme places reliably. ## A decision framework The following questions are diagnostic, not prescriptive. Answer them honestly. **Question 1: How do you feel about 50-70% travel, including overnight stays?** - Comfortable or indifferent: CRA is viable. PV is still also viable. - Uncomfortable or not feasible: PV, CDM, or regulatory affairs. **Question 2: Would you rather spend your day reviewing data and writing, or visiting sites and solving problems in real time?** - Data review and writing: PV. - Active problem-solving in varied environments: CRA. **Question 3: Do you prioritise maximum long-term salary ceiling or career stability and predictability?** - Maximum ceiling: CRA has a slight advantage. - Stability and predictability: PV is marginally more recession-resistant. **Question 4: Do you prefer shift work / structured hours, or variable hours tied to project demands?** - Structured hours: PV (though CRO PV can involve rotating shifts). - Flexible with some unpredictability: CRA. **Question 5: Are you a B.Pharm/M.Pharm or MBBS/BDS graduate with specific interest in drug safety and regulatory science?** - Strong interest in drug safety, pharmacology, regulatory: PV suits. - Strong interest in trial operations, hospital environments, protocol compliance: CRA suits. There is no wrong answer here. The professionals who succeed in both tracks are those who chose the role that matched their actual working style, not the one that looked better on paper or paid a few thousand rupees more at entry. ## Both paths are valid career choices The pharmacovigilance vs CRA comparison is not a contest with a winner. They are different professional identities. A senior PV Manager at Cipla with a decade of drug safety expertise is not less successful than a Clinical Project Manager at IQVIA with the same experience; they are at similar career levels with similar compensation, with fundamentally different day-to-day work. The question is which kind of professional you want to become. If the honest answer to the travel question is that 50-70% travel is genuinely manageable for you, and if you find the prospect of field monitoring work more engaging than desk-based data analysis, choose CRA. If you prefer structured analytical work, are drawn to the regulatory science of drug safety, and want a desk-based career, PV is the better fit. Both paths require structured training. iLearn CRI's [Pharmacovigilance programme](/courses/pharmacovigilance/) and [Clinical Research Associate programme](/courses/clinical-research-associate-cra/) are both built for B.Pharm, M.Pharm, and life sciences graduates entering from any background, with hands-on platform training and placement support into Pune's pharma corridor. Reach out via WhatsApp with your background and the decision-relevant factors above; we can help you think through the right path for your specific situation. --- ## Pune Clinical Research Job Market Report 2026: Employers, Salaries, and Hiring Outlook **URL:** https://ilearncri.com/blog/pune-clinical-research-jobs-2026/ **Author:** iLearn CRI Editorial **Published:** 2026-05-03 **Category:** jobs-and-salary **Summary:** Pune is India's most active clinical research job market outside Bengaluru, with over 2,000 active openings across CROs, pharma companies, and service providers in 2026. This market report covers the top 15 employers, their hiring patterns, salary bands, and where the city's clinical research corridor is expanding. **FAQs:** *Q: Which area of Pune has the most clinical research jobs?* A: The highest concentration of clinical research employers in Pune is in the western corridor: Hinjewadi (IT and pharma tech companies, CRO offices), Wakad, Baner, and Balewadi. PCMC (Pimpri-Chinchwad), including Bhosari and Chakan, houses manufacturing and larger pharma operations (Cipla, Lupin, Wockhardt, Emcure plants). The Kothrud-Karve Nagar belt has some smaller CROs and training organisations. For CRA and PV roles, the Hinjewadi-Wakad-Baner corridor is where most openings are concentrated. *Q: What is the starting salary for clinical research jobs in Pune in 2026?* A: Starting salaries in Pune's clinical research market in 2026 range from Rs 3.0-4.0 LPA for Medical Coding Associates to Rs 3.5-4.5 LPA for PV Associates, Rs 4.2-5.5 LPA for CRA Level I, and Rs 3.8-4.8 LPA for Clinical Data Management Associates. Sponsor-side starting salaries at pharma companies are 15-20% higher than equivalent CRO roles. Top-tier global CROs (IQVIA, ICON, Parexel) pay 10-15% more than mid-tier CROs at the entry level. *Q: How many clinical research jobs are there in Pune?* A: Pune has approximately 2,000-2,500 active clinical research openings at any given time in 2026, across CRO and pharma employer categories. PV roles account for roughly 35-40% of the total. CRA and clinical monitoring roles are 20-25%. CDM is 15%. Medical coding, regulatory affairs, and medical writing together account for the remaining 20-25%. Total clinical research employment in Pune across all levels is estimated at 18,000-22,000 professionals. *Q: Which companies in Pune hire the most freshers in clinical research?* A: The highest-volume fresher recruiters in Pune's clinical research market are Lambda Therapeutic Research, Syngene International, Veeda Clinical Research, Sciformix (Labcorp), Omega Healthcare, and Optum (for medical coding). These CROs and service companies run structured fresher intake batches and have the training infrastructure to onboard candidates with clinical research training but no prior industry experience. Cipla and Lupin also hire a significant number of freshers directly into PV and clinical operations. *Q: Do I need IQVIA or ICON experience to get hired in Pune clinical research?* A: No. Prior experience at IQVIA or ICON is not a prerequisite for clinical research jobs in Pune. The market has a broad spectrum of employers, from large global CROs to mid-tier domestic CROs and pharma company in-house teams. Freshers from quality training programmes are hired across this spectrum. IQVIA, ICON, and Parexel do recruit freshers directly, typically through campus placement partnerships with established training institutes. Pune is India's second-largest clinical research employment market after Bengaluru, and by some measures it is growing faster. The city's combination of pharmaceutical manufacturing infrastructure (Cipla, Lupin, Wockhardt, Emcure, Sun Pharma all have significant Pune operations), a dense CRO ecosystem, and strong talent supply from Maharashtra's pharmacy and life sciences colleges creates a self-reinforcing employment cluster. This report covers the top employers, their hiring patterns and role types, salary bands, the geographic distribution of openings within Pune, and the skills that are differentiating candidates in 2026. The numbers are based on active job posting analysis, recruiter conversations, and placement data from Pune's clinical research training sector. ## Pune's clinical research employment landscape in numbers | Metric | 2024 estimate | 2026 estimate | Change | |---|---|---|---| | Active clinical research professionals | 16,000-18,000 | 18,000-22,000 | +12-15% | | Active job openings (any given point) | 1,400-1,700 | 2,000-2,500 | +35-40% | | PV roles as % of total | 32% | 37% | +5pp | | CRA/monitoring roles as % of total | 22% | 21% | -1pp | | CDM roles as % of total | 18% | 15% | -3pp | | Medical coding as % of total | 16% | 14% | -2pp | | Regulatory/medical writing | 12% | 13% | +1pp | PV's growing share reflects the increasing ICSR outsourcing flowing through Pune CROs from US and EU clients. CDM's declining share reflects automation and consolidation in the data management function. ## The top 15 employers in Pune's clinical research market ### 1. Syngene International **Headquarters:** Bengaluru (major Pune operations) **Pune location:** Baner, with satellite offices in Hinjewadi **Annual hiring volume (Pune):** 200-300 clinical research professionals **Role types:** PV Associates, Senior PV Associates, CRAs, Clinical Data Scientists, Medical Writers **Typical CTC bands:** PV Associate Rs 3.8-5.0 LPA; CRA Level I Rs 4.5-6.0 LPA; Senior PV Rs 7-10 LPA **Notable:** Syngene has one of Pune's most structured fresher onboarding programmes for PV and CRA roles. They have a campus placement relationship with several Pune training institutes. AI-assisted PV tools are deployed in their operations, making platform familiarity a genuine differentiator. ### 2. Lambda Therapeutic Research **Headquarters:** Ahmedabad (major Pune CRO operations) **Pune location:** Wakad **Annual hiring volume (Pune):** 150-200 professionals **Role types:** PV Associates, ICSR processors, CRAs, Regulatory Affairs **Typical CTC bands:** PV fresher Rs 3.5-4.5 LPA; CRA Level I Rs 4.2-5.0 LPA **Notable:** Lambda is one of Pune's highest-volume fresher recruiters. Their PV operations process significant global caseloads. Mid-level PV growth is solid, with internal promotion timelines of 18-24 months for performing associates. ### 3. Veeda Clinical Research **Headquarters:** Ahmedabad (Pune CRO presence) **Pune location:** Baner **Annual hiring volume (Pune):** 100-150 professionals **Role types:** CRAs, PV Associates, Clinical Operations, Regulatory Affairs **Typical CTC bands:** CRA Level I Rs 4.0-5.2 LPA; PV Associate Rs 3.5-4.2 LPA **Notable:** Veeda conducts BA/BE studies and Phase II-IV clinical trials. Their CRA roles have strong therapeutic area diversity, which is valuable for career development. They are piloting AI-assisted triage tools in their PV operations. ### 4. Sciformix (Labcorp Drug Development) **Headquarters:** US (India operations in Pune) **Pune location:** Kharadi, EON IT Park **Annual hiring volume (Pune):** 200-280 professionals **Role types:** PV Associates (ICSR processing, aggregate reporting), Medical Writers, Signal Detection **Typical CTC bands:** PV fresher Rs 3.8-4.8 LPA; Senior PV Rs 8-12 LPA; Medical Writer Rs 5-9 LPA **Notable:** Sciformix (now operating under Labcorp) is one of the largest PV outsourcing operations in Pune, processing significant global caseloads for US and EU clients. It is an especially strong employer for those interested in aggregate reporting and signal detection at mid-career. ### 5. IQVIA **Headquarters:** US (India operations in Pune and Bengaluru) **Pune location:** Hinjewadi, Baner **Annual hiring volume (Pune):** 120-180 professionals **Role types:** CRAs, PV Specialists, CDM, Regulatory Submissions, Medical Writing **Typical CTC bands:** CRA Level I Rs 4.8-6.0 LPA; PV Associate Rs 4.0-5.0 LPA; CRA Level II Rs 7.5-10 LPA **Notable:** IQVIA pays 10-15% above mid-tier CRO market rates. Their global client exposure is strong, particularly in oncology and rare disease trials. The interview process is more rigorous than domestic CROs. Placement into IQVIA from a training programme is a strong resume signal for future moves. ### 6. ICON plc **Headquarters:** Ireland (India operations in Pune and Chennai) **Pune location:** Baner, Wakad **Annual hiring volume (Pune):** 80-130 professionals **Role types:** CRAs, Clinical Data Reviewers, PV Associates, Regulatory **Typical CTC bands:** CRA Level I Rs 4.5-5.8 LPA; Senior CRA Rs 12-16 LPA **Notable:** ICON's Pune operations focus significantly on CRA roles for their global clinical trial portfolio. They have a structured CRA development programme with regular cohort hiring. Promotion cycles are 18-24 months for performing CRAs. ### 7. Parexel International **Headquarters:** US (India operations in Pune, Hyderabad, Mumbai) **Pune location:** Baner **Annual hiring volume (Pune):** 70-110 professionals **Role types:** CRAs, Clinical Project Managers, PV Specialists, Regulatory **Typical CTC bands:** CRA Level I Rs 4.5-5.8 LPA; Clinical Project Manager Rs 22-32 LPA **Notable:** Parexel's Pune team is weighted toward more experienced professionals, with fewer pure fresher positions than Lambda or Syngene. Strong for mid-career CRAs looking to transition from domestic to global trial portfolios. ### 8. Cipla Limited **Headquarters:** Mumbai (major Pune operations) **Pune location:** Bhosari, Pimpri **Annual hiring volume (Pune):** 100-150 clinical research professionals **Role types:** PV Associates, CRAs, Regulatory Affairs, Medical Affairs, Clinical Operations **Typical CTC bands:** PV fresher Rs 4.5-5.5 LPA; CRA Level I Rs 5.0-6.5 LPA (sponsor-side premium) **Notable:** Cipla's sponsor-side positions pay 15-20% more than equivalent CRO roles at entry level. Working at Cipla provides direct regulatory submission experience that is valued across the industry. PV roles at Cipla involve global pharmacovigilance obligations, not just India-focused safety monitoring. ### 9. Lupin Limited **Headquarters:** Mumbai (major Pune operations) **Pune location:** Viman Nagar, Baner, Pimpri **Annual hiring volume (Pune):** 80-120 clinical research professionals **Role types:** PV Associates, Regulatory Affairs, Clinical Development, Medical Affairs **Typical CTC bands:** PV Associate Rs 4.2-5.2 LPA; Senior PV Rs 8-12 LPA **Notable:** Lupin's clinical research operations span domestic and global markets. The company's generics-to-innovation pipeline is expanding, meaning clinical trial headcount is growing. Their Pune team runs a significant portion of India-specific PV obligations. ### 10. Emcure Pharmaceuticals **Headquarters:** Pune **Pune location:** Hinjewadi, Kothrud **Annual hiring volume (Pune):** 60-90 clinical research professionals **Role types:** Regulatory Affairs, Medical Affairs, PV, Clinical Operations **Typical CTC bands:** PV fresher Rs 3.8-4.8 LPA; Regulatory Affairs Rs 4.5-6.0 LPA **Notable:** As a Pune-headquartered company, Emcure provides good access and stability for Pune-based professionals. Their clinical pipeline spans gynaecology, oncology, and cardiology. Regulatory affairs roles at Emcure provide strong domestic regulatory experience with CDSCO. ### 11. Wockhardt Limited **Headquarters:** Mumbai (significant Pune operations) **Pune location:** Aurangabad Road, MIDC areas **Annual hiring volume (Pune):** 50-75 professionals **Role types:** PV, Regulatory Affairs, Medical Affairs, CRAs (for investigator-initiated studies) **Typical CTC bands:** PV Associate Rs 3.8-4.5 LPA; Regulatory Rs 4.5-6.0 LPA **Notable:** Wockhardt has a biologics pipeline that creates demand for clinical operations and regulatory professionals with biologics experience, a differentiator in the Pune market. ### 12. Glenmark Pharmaceuticals **Headquarters:** Mumbai (Pune operations) **Pune location:** MIDC Andheri (Pune-side operations administered from this office) **Annual hiring volume (Pune):** 40-65 professionals **Role types:** PV Associates, Clinical Research Associates, Medical Affairs **Typical CTC bands:** PV Associate Rs 4.0-5.0 LPA; CRA Level I Rs 4.5-5.5 LPA **Notable:** Glenmark's specialty brands in dermatology, respiratory, and oncology create interesting therapeutic area exposure. Their PV team is global and handles multiple PSUR cycles. ### 13. Sun Pharmaceutical Industries **Headquarters:** Mumbai (Pune operations) **Pune location:** Baner, Wakad **Annual hiring volume (Pune):** 60-90 professionals **Role types:** Regulatory Affairs, PV, Clinical Operations, Medical Writing **Typical CTC bands:** PV Associate Rs 4.2-5.2 LPA; Regulatory Rs 5.0-7.0 LPA **Notable:** Sun Pharma's specialty and innovator pipeline (Ilumya, Cequa) creates clinical development roles that go beyond generic regulatory work. Their Pune office handles a mix of India regulatory affairs and global PV functions. ### 14. Reliance Life Sciences **Headquarters:** Navi Mumbai (Pune operations) **Pune location:** Hinjewadi **Annual hiring volume (Pune):** 40-70 professionals **Role types:** CRAs, Clinical Operations, Regulatory Affairs **Typical CTC bands:** CRA Level I Rs 4.0-5.0 LPA; Clinical Operations Rs 5.0-7.0 LPA **Notable:** Reliance Life Sciences runs biopharmaceuticals and biosimilars, creating a distinctive trial portfolio in a therapeutic area where India is globally competitive. CRA experience in biosimilar trials carries strong value for sponsor-side moves. ### 15. Mylan / Viatris **Headquarters:** US (India operations in Pune and Hyderabad) **Pune location:** Baner, Hinjewadi **Annual hiring volume (Pune):** 50-80 professionals **Role types:** PV Associates, Regulatory Affairs, Medical Affairs, Clinical Operations **Typical CTC bands:** PV Associate Rs 4.0-5.0 LPA; Senior PV Rs 8-11 LPA **Notable:** Viatris's global generic and branded portfolio creates a high-volume PV environment with exposure to multiple therapeutic areas simultaneously. The PV team processes ICSRs for products marketed across 165 countries, providing broad global safety exposure. ## Salary trends: 2024 to 2026 | Role | 2024 entry CTC (Pune) | 2026 entry CTC (Pune) | 2-year change | |---|---|---|---| | PV Associate | Rs 3.2-4.0 LPA | Rs 3.5-4.5 LPA | +8-12% | | CRA Level I | Rs 3.8-5.0 LPA | Rs 4.2-5.5 LPA | +10-13% | | CDM Associate | Rs 3.5-4.5 LPA | Rs 3.8-4.8 LPA | +7-10% | | Medical Coding Associate | Rs 2.8-3.5 LPA | Rs 3.0-4.0 LPA | +7-14% | | Regulatory Affairs (entry) | Rs 4.0-5.5 LPA | Rs 4.5-6.5 LPA | +10-18% | | Medical Writer (entry) | Rs 4.5-6.0 LPA | Rs 5.0-7.0 LPA | +11-17% | Salary growth has been strongest in medical writing and regulatory affairs, reflecting demand growth that has outpaced supply. PV and CRA entry salaries have grown at 8-13% over two years, roughly in line with the broader pharma sector and above general IT-sector growth rates for the same period. The salary bands at sponsor-side companies (Cipla, Lupin, Sun Pharma) remain 15-20% higher than equivalent CRO roles across all experience levels. This premium has been consistent. ## Geographic concentration of openings within Pune Pune's clinical research employment is not evenly distributed. Understanding where the clusters are matters for commute decisions and for understanding which training locations give the best proximity to employers. **Hinjewadi and Wakad (western suburbs):** The highest concentration of CRO offices and tech-enabled pharma operations. IQVIA, ICON, Lambda, Syngene Pune operations, Emcure, and several mid-tier CROs are headquartered here. This corridor accounts for roughly 45-50% of Pune's total clinical research openings. **Baner and Balewadi:** Growing rapidly as a CRO hub, with Parexel, Veeda, and multiple mid-tier CROs. Baner has become a preferred location for global CROs setting up India delivery centres. About 15-20% of openings. **PCMC (Pimpri-Chinchwad, Bhosari, Chakan):** Primarily pharma manufacturing companies (Cipla, Lupin, Wockhardt, Glenmark plants). Regulatory affairs and PV roles attached to manufacturing operations are concentrated here. About 20-25% of openings. **Kothrud, Karve Nagar, Deccan:** Smaller CROs, training organisations, some pharma sales and medical affairs. About 5-8% of openings. **Viman Nagar, Kharadi:** Some CRO and pharma offices. Sciformix's Kharadi operation is the largest clinical research employer in this area. For candidates prioritising access to the largest number of openings, the Hinjewadi-Wakad-Baner corridor is where to focus. Candidates interested specifically in sponsor-side pharma roles should look at PCMC and Baner. ## Skills in highest demand in 2026 Based on a review of active job postings from Pune's clinical research employers in Q1 2026, the following skills appeared most frequently as requirements: **Most cited in PV postings:** - Oracle Argus Safety (specified in 68% of senior PV postings) - MedDRA proficiency (specified in all ICSR-related postings) - ICH E2A-E2F knowledge - ICSR narrative writing - Signal detection basics (specified in 35% of mid-senior postings) **Most cited in CRA postings:** - ICH GCP E6 (specified in all postings) - Electronic Data Capture (Medidata Rave, Oracle InForm specified in 70% of postings) - Protocol deviation management - RBQM/centralised monitoring (specified in 42% of postings, growing rapidly) - Therapeutic area specifics (oncology preferred in 38% of postings) **Cross-functional skills in demand:** - Regulatory writing (PSUR/PBRER, clinical study reports) - CTMS platform familiarity (Veeva Vault, BioClinica) - Remote monitoring tools - English clinical writing proficiency RBQM and centralised monitoring skills are the fastest-growing requirement in CRA postings, reflecting the ICH E6(R3) shift in monitoring methodology. Employers running global trials expect CRAs to understand risk-based monitoring concepts, not just execute fixed monitoring schedules. ## Hiring outlook for 2026-2027 Several structural factors suggest Pune's clinical research job market will continue expanding over the next 12-18 months: **India's growing clinical trial volume.** CDSCO approval timelines for new trials have improved, and India's inclusion in global multi-regional trials is growing. More trials starting in India means more CRA demand. **ICSR outsourcing growth.** Global pharma companies continue to outsource PV processing to Indian CROs. Pune's established outsourcing infrastructure means this growth flows disproportionately here. **Domestic pharma's regulatory expansion.** Indian pharma companies pursuing US FDA and EMA market approvals need global regulatory and safety teams. Cipla, Lupin, and Sun Pharma are all expanding in this direction, creating mid-senior level demand for professionals with global regulatory experience. **AI integration creating new specialist roles.** As AI tools are deployed in PV and CDM operations, new roles emerge: PV system administrators, AI quality auditors, data quality specialists. These are net additions to headcount, not replacements. **Generic growth limitations.** The generic pharma market is more competitive and margin-compressed than five years ago. This is pushing Indian pharma companies toward specialty, complex generics, and innovation, all of which require more clinical research infrastructure per rupee of revenue. ## Where to start: training programmes and placement infrastructure The quality of training matters more in Pune's clinical research market than in most cities, because Pune employers can be selective. A B.Pharm graduate with no clinical research training competing against graduates of structured programmes with Argus Safety hands-on experience and CRA simulation visits will lose that competition consistently. The training factors that employers in Pune's clinical research market actually care about: 1. **ICH-GCP certification** for CRA roles. Required at every employer. 2. **Platform hands-on training.** Argus Safety or Veeda Vault Safety for PV; Medidata Rave or Oracle InForm for CRA/CDM. 3. **Industry-aligned faculty.** Instructors who are currently working in Pune CROs or pharma companies, not academic faculty without industry contact. 4. **Placement relationships.** Warm introductions to Pune's hiring managers, not just resume drops. 5. **Recent curriculum.** ICH E6(R3) concepts, AI-integrated workflow awareness, and RBQM principles should now be in the curriculum. iLearn CRI's programmes across [pharmacovigilance](/courses/pharmacovigilance/), [clinical research associate](/courses/clinical-research-associate-cra/), and other clinical research specialisations are built for this market specifically. Our placement track connects graduates into the Hinjewadi-Wakad-Baner corridor employers covered in this report. Pune's clinical research market in 2026 is the most active it has been in a decade, and the structural tailwinds suggest that will continue. For candidates with the right training and skills alignment, the placement window has rarely been more favourable. --- ## CRA Salary in India 2026: Complete Breakdown by Experience **URL:** https://ilearncri.com/blog/cra-salary-india-2026/ **Author:** iLearn CRI Editorial **Published:** 2026-04-28 **Updated:** 2026-04-28 **Category:** jobs-and-salary **Summary:** From a fresher Level I CRA at ₹ 4.2 LPA to a Lead CRA at ₹ 18 LPA, here's how CRA compensation in India actually breaks down across experience bands, cities, and sponsor vs CRO settings. **FAQs:** *Q: What is the average CRA salary in India?* A: The average CRA salary in India in 2026 ranges from ₹ 4.2 LPA for freshers (CRA Level I) to ₹ 18+ LPA for senior CRAs and lead CRAs. Mid-level CRA II roles typically pay ₹ 7–10 LPA. Sponsor-side CRAs at large pharma companies generally earn 15–20% more than CRO-side CRAs at the same experience level. *Q: How fast does CRA salary grow?* A: CRA compensation grows faster than most pharma roles. The typical trajectory: Level I (0–2 yrs) ₹ 4–6 LPA → Level II (2–4 yrs) ₹ 7–10 LPA → Level III/Senior (4–7 yrs) ₹ 12–18 LPA → Lead CRA / Clinical Project Manager (7+ yrs) ₹ 18–30+ LPA. Growth depends heavily on therapeutic area exposure, monitoring volume, and protocol complexity handled. *Q: Which city pays CRAs the most in India?* A: Mumbai and Bengaluru tend to pay 10–20% more than other Indian cities at every experience level. Pune is competitive with Bengaluru for CRA salaries due to the dense CRO ecosystem (Syngene, Veeda, Lambda). Delhi-NCR and Hyderabad are next, followed by Ahmedabad, Chennai, and tier-2 cities. If you're considering a career as a Clinical Research Associate—or you're already in the field and wondering whether your CTC is fair—this is the most current breakdown of CRA compensation in India for 2026, by experience level, city, and employer type. The numbers below are aggregated from active job postings, recruiter conversations, and our placement data across Pune's CRO ecosystem. They reflect realistic market compensation, not aspirational ranges. ## The CRA career ladder in India Most CROs and pharma sponsors use a four-tier CRA progression: | Level | Experience | Typical Title | |---|---|---| | Level I | 0–2 years | CRA, Junior CRA, CRA Trainee | | Level II | 2–4 years | CRA II, Site Monitor | | Level III / Senior | 4–7 years | Senior CRA, Lead Site Monitor | | Lead / CPM | 7+ years | Lead CRA, Clinical Project Manager | Promotion timelines vary by CRO. Aggressive global CROs (IQVIA, ICON, Parexel) typically promote on a 18–24 month cycle if you hit utilization and quality metrics. Sponsor-side roles at large pharma move slower (24–36 months) but with stronger compensation jumps. ## CRA Level I (0–2 years experience) This is the entry tier, where most graduates from clinical research training programs start. | Setting | CTC range (2026) | |---|---| | Mid-tier CRO (Pune, Bengaluru) | ₹ 3.8–5.0 LPA | | Top-tier CRO (IQVIA, ICON, Parexel) | ₹ 4.5–6.0 LPA | | Sponsor-side (Cipla, Sun Pharma, Lupin) | ₹ 5.0–7.0 LPA | | Niche oncology/rare disease CRO | ₹ 5.5–7.5 LPA | **What drives the high end:** therapeutic area exposure (oncology, cardiology pay premium), prior internship at a CRO, ICH-GCP certification, and language skills (Tamil, Telugu, Bengali) for multi-site coverage. A B.Pharm or M.Pharm graduate from Pune typically starts at ₹ 4.2 LPA at a mid-tier CRO. With a strong placement profile—say, internship + GCP cert + a regional language—₹ 5.5 LPA at a top-tier CRO is achievable for the right candidate. ## CRA Level II (2–4 years experience) This is where CRA careers either compound rapidly or stagnate. The difference is largely about therapeutic area progression and monitoring volume. | Setting | CTC range (2026) | |---|---| | Mid-tier CRO | ₹ 6.5–8.5 LPA | | Top-tier CRO | ₹ 7.5–10.0 LPA | | Sponsor-side | ₹ 8.5–12.0 LPA | | Specialized therapeutic areas | ₹ 9.0–13.0 LPA | **Promotion lever:** Level II promotion typically requires demonstrated competence in independent site monitoring (no co-monitoring needed), at least 8–12 sites monitored, and exposure to at least 2 therapeutic areas. CRAs who pick up oncology, rare disease, or device trials at this stage compound 30–50% faster than general therapeutic area CRAs. ## CRA Level III / Senior CRA (4–7 years) At this level, you're managing complex protocols, mentoring junior CRAs, and often running site selection and feasibility for new trials. | Setting | CTC range (2026) | |---|---| | Mid-tier CRO | ₹ 10–13 LPA | | Top-tier CRO | ₹ 12–16 LPA | | Sponsor-side | ₹ 14–20 LPA | | Specialized / oncology lead CRA | ₹ 15–22 LPA | **Compensation gets variable here.** Stock options, bonuses tied to project closure, and travel allowances add 10–25% on top of base CTC. Senior CRAs at sponsor companies often hit ₹ 18+ LPA all-in; specialized oncology Senior CRAs can cross ₹ 22 LPA. ## Lead CRA / Clinical Project Manager (7+ years) This is the inflection point where CRAs decide between staying as monitoring specialists (Lead CRA) or moving into management (CPM, Clinical Trial Manager). | Role | CTC range (2026) | |---|---| | Lead CRA (CRO) | ₹ 18–25 LPA | | Clinical Project Manager (CRO) | ₹ 22–32 LPA | | Clinical Trial Manager (Sponsor) | ₹ 28–45 LPA | | Therapeutic Lead / Director (Sponsor) | ₹ 40+ LPA | **Sponsor-side > CRO-side at this level**, often significantly. Pharma companies pay a premium for proven trial managers because the cost of a delayed trial is enormous. ## City-by-city CRA salary breakdown Geography matters more than people expect. Same CRO, same role, different city—up to 25% delta. | City | Level I | Level III | Lead/CPM | |---|---|---|---| | Mumbai | ₹ 5.0–6.5 | ₹ 13–18 | ₹ 25–35 | | Bengaluru | ₹ 4.8–6.2 | ₹ 12–17 | ₹ 24–33 | | Pune | ₹ 4.5–6.0 | ₹ 12–16 | ₹ 22–32 | | Delhi-NCR | ₹ 4.5–6.0 | ₹ 11–15 | ₹ 21–30 | | Hyderabad | ₹ 4.2–5.5 | ₹ 10–14 | ₹ 20–28 | | Ahmedabad | ₹ 4.0–5.2 | ₹ 9–13 | ₹ 18–26 | Pune punches above its weight because of the CRO concentration—Syngene, Veeda, Lambda, Reliance Life Sciences, and growing operations of IQVIA, ICON, and Parexel. CRAs in Pune typically have more lateral mobility than in Hyderabad or Ahmedabad, which keeps salaries competitive. ## What actually moves the needle on CRA pay Five factors compound CRA compensation faster than years of experience alone: 1. **Therapeutic area depth.** Oncology and rare disease CRAs earn 20–30% more than general TA CRAs at every level. 2. **Monitoring volume.** CRAs who have monitored 30+ sites get hired into senior roles 12–18 months earlier than those with limited site exposure. 3. **Sponsor exposure.** Direct exposure to FDA, EMA, or PMDA submissions makes you 25–40% more valuable. 4. **Languages.** Hindi + 2 regional languages dramatically expand your hireable site footprint. 5. **Risk-Based Quality Management (RBQM) skills.** As CROs shift toward centralized monitoring, CRAs with RBQM experience are increasingly differentiated. ## How to start a CRA career in 2026 If you're a B.Pharm, M.Pharm, BDS, MBBS, or B.Sc/M.Sc Life Sciences graduate, the standard path into a CRA role involves three steps: 1. **Structured CRA training**—a focused 6-month industry-led program covering ICH-GCP, site monitoring, SDV, EDC platforms, and trial management 2. **ICH-GCP certification**—TransCelerate-recognized certifications carry weight with sponsors and CROs 3. **Placement support**—warm introductions to hiring managers, mock interviews with practicing CRAs, and resume calibration to the specific patterns Pune CROs hire on Most graduates from quality programs with this structure place into Level I CRA roles at ₹ 4.2–5.5 LPA within 60–90 days of course completion. If you're considering a clinical research career and want to understand how iLearn CRI's [Clinical Research Associate program](/courses/clinical-research-associate-cra/) prepares you for these roles, reach out via WhatsApp—we can walk through your specific background and the right path forward. --- ## Clinical Research Career After B.Pharm in India: Complete Guide 2026 **URL:** https://ilearncri.com/blog/clinical-research-after-bpharm/ **Author:** iLearn CRI Editorial **Published:** 2026-04-25 **Category:** career-guide **Summary:** B.Pharm graduates have multiple distinct entry paths into clinical research — each with different skills, training duration, and salary trajectory. Here's the complete 2026 picture. **FAQs:** *Q: Is clinical research a good career option after B.Pharm?* A: Clinical research is one of the most consistent and well-compensated career paths for B.Pharm graduates in India. It offers structured progression, global skill portability, and salary trajectories that compound faster than most pharma manufacturing or sales roles. Pune, Mumbai, and Bengaluru have the largest concentration of clinical research employers (CROs and sponsor companies). *Q: What is the best clinical research role after B.Pharm?* A: The two most accessible and high-value entry roles for B.Pharm graduates are Pharmacovigilance Associate (drug safety monitoring) and Clinical Research Associate or CRA (trial site monitoring). Pharmacovigilance has higher initial demand and shorter training timelines; CRA has better long-term compensation ceiling. Both pay ₹ 3.5–6 LPA at entry level for B.Pharm graduates with structured training. *Q: How long does clinical research training take after B.Pharm?* A: Specialized programs (Pharmacovigilance, CRA, Medical Coding) typically take 3–6 months. A comprehensive PG Diploma in Clinical Research is 9–12 months. Most B.Pharm graduates can transition into a clinical research role within 6–12 months of starting structured training, including placement preparation. If you're a B.Pharm graduate facing the question of what to do next, clinical research deserves serious consideration. It is one of the few pharma career paths that combines strong starting salaries, fast compensation growth, structured progression, and globally portable skills—without requiring a master's degree to begin. This guide covers the realistic options, the genuine trade-offs, and the practical steps to start a clinical research career in India in 2026. ## Why clinical research suits B.Pharm graduates The B.Pharm curriculum already covers a substantial portion of what clinical research roles require: pharmacology, drug development, regulatory affairs, biostatistics fundamentals, and pharmaceutical chemistry. What it doesn't cover are the **operational and compliance layers**—how trials are run, how drug safety is monitored in production, how data is processed against ICH-GCP guidelines. These operational layers are exactly what specialized clinical research training fills in. The result is that B.Pharm graduates with 3–6 months of focused clinical research training are highly hireable at CROs and pharma companies, often more so than M.Sc graduates with similar training because of the foundational pharma context. ## The four entry paths after B.Pharm There are four distinct clinical research roles that hire B.Pharm graduates directly after structured training. Each has a different skill profile, training timeline, and trajectory. ### Path 1: Pharmacovigilance (PV) **What you do:** Monitor drug safety throughout a product's lifecycle. Process Individual Case Safety Reports (ICSRs), code adverse events using MedDRA, write narratives, and contribute to aggregate safety reports (PSURs, PBRERs). **Training duration:** 6 months **Entry salary (Pune):** ₹ 3.5–4.5 LPA **3-year salary:** ₹ 6–8 LPA **5-year salary:** ₹ 9–13 LPA **Best for:** B.Pharm graduates who like structured, process-driven work and want a desk-based role with predictable hours. **Pune employers:** Cipla, Lupin, Mylan, Wockhardt, Glenmark, Syngene, Veeda, Lambda PV is the **highest-volume entry path** in Pune right now. Roles are abundant, training is well-defined, and the work is genuinely interesting if you enjoy applying medical knowledge to safety analysis. ### Path 2: Clinical Research Associate (CRA) **What you do:** Monitor clinical trials at hospital sites. Verify that data in the Case Report Form matches source documents (SDV), ensure ICH-GCP compliance, write monitoring reports, manage protocol deviations. **Training duration:** 6 months **Entry salary (Pune):** ₹ 4.2–5.5 LPA **3-year salary:** ₹ 8–11 LPA **5-year salary:** ₹ 12–18 LPA **Best for:** B.Pharm graduates comfortable with travel (50–70%), detail-oriented, and interested in a faster-growing career trajectory. **Pune employers:** Syngene, Veeda, Lambda, IQVIA, ICON, Parexel, Reliance Life Sciences CRA roles have a **higher salary ceiling** than PV but require willingness to travel. The role compounds faster—a Senior CRA with 4–6 years of experience earns significantly more than a Senior PV professional at the same career stage. ### Path 3: Clinical Data Management (CDM) **What you do:** Manage the clinical trial database from design through database lock. Build CRFs in EDC platforms, write edit checks, perform data review, manage queries, and prepare data for statistical analysis. **Training duration:** 4–6 months **Entry salary (Pune):** ₹ 3.8–4.8 LPA **3-year salary:** ₹ 7–9 LPA **5-year salary:** ₹ 10–14 LPA **Best for:** B.Pharm graduates with stronger analytical/technical inclinations. Some SAS programming knowledge is a major advantage. **Pune employers:** Cytel, Syngene, Veeda, Sciformix, Tata Consultancy Services Life Sciences CDM is increasingly automated, which means modern CDM professionals need stronger technical skills (SAS, Python for clinical data, EDC platform configuration) than 5 years ago. The roles that remain command good compensation. ### Path 4: Medical Coding **What you do:** Translate medical procedures, diagnoses, and services into standardized codes (ICD-10-CM, CPT, HCPCS) for insurance claims and pharma data systems. **Training duration:** 3 months **Entry salary (Pune):** ₹ 3.0–4.0 LPA **3-year salary:** ₹ 5–7 LPA **5-year salary:** ₹ 7–10 LPA **Best for:** B.Pharm graduates wanting the fastest entry path with minimal travel. Best for career-switchers, parents returning to work, or those preferring strict 9–5 hours. **Pune employers:** Optum, R1 RCM, Omega Healthcare, Cognizant, multiple US-aligned coding firms Medical coding has the **fastest entry timeline** but a lower long-term ceiling. CPC certification is essential for any serious career here. ## Comparing the four paths | Factor | PV | CRA | CDM | Medical Coding | |---|---|---|---|---| | Training duration | 6 mo | 6 mo | 4–6 mo | 3 mo | | Entry CTC | ₹ 3.5–4.5L | ₹ 4.2–5.5L | ₹ 3.8–4.8L | ₹ 3.0–4.0L | | 5-year CTC | ₹ 9–13L | ₹ 12–18L | ₹ 10–14L | ₹ 7–10L | | Travel required | Low | High | Low | None | | Hiring volume (Pune) | Very high | High | Medium | High | | Long-term ceiling | Medium | High | Medium | Low | | Work hours | Predictable | Variable | Predictable | Strict shifts | ## How to choose the right path A few diagnostic questions to narrow this down: **Are you willing to travel 50–70% of the time?** Yes → CRA. No → PV, CDM, or Medical Coding. **Do you prefer analytical/data-heavy work?** Yes → CDM or PV (signal detection track). No → CRA or Medical Coding. **Do you need to start earning fast?** Yes → Medical Coding (3 months training). No → PV or CRA give better long-term returns. **Do you have strong SAS/programming aptitude?** Yes → CDM has compounding advantages with technical skills. **Are you comfortable with regulatory/compliance work?** Yes → PV or CRA. No → CDM or Medical Coding. ## What you actually need to learn Regardless of path, B.Pharm graduates need three things to be competitive: 1. **Domain-specific training**—the structured 3–6 month program for your chosen path 2. **ICH-GCP certification**—essential for any clinical research role (often included in CRA/PV programs) 3. **Platform exposure**—Argus or ARISg for PV, EDC platforms for CRA/CDM, ICD coding software for medical coding Without all three, you'll struggle to convert interviews into offers, regardless of how strong your B.Pharm grades were. ## The Pune advantage If you're a B.Pharm graduate located in Maharashtra (or willing to relocate to Pune), you have a structural advantage. Pune is one of India's two largest clinical research hubs (Bengaluru being the other), with concentrated employer demand across all four paths. The pharma corridor stretching from Hinjewadi through Wakad, Bhosari, and Chakan houses operations of every major Indian pharma company and most global CROs. Lateral mobility between employers is strong, salary benchmarks are transparent, and senior career opportunities (Lead CRA, PV Manager, CDM Lead) are abundant. ## Choosing where to train The right training program for B.Pharm graduates entering clinical research should have: - **Industry-active faculty**—instructors who currently work in the field, not academic theorists - **Hands-on platform training**—Argus, ARISg, Medidata Rave, EDC platforms, not just slides - **ICH-GCP-aligned curriculum**—the global hiring benchmark - **Real placement infrastructure**—not just a notice board, but warm introductions to Pune's pharma corridor - **Small batch sizes**—24 students or fewer, so you actually get hands-on time If you're considering iLearn CRI, our [Pharmacovigilance program](/courses/pharmacovigilance/) and [CRA training](/courses/clinical-research-associate-cra/) are both built around these principles. Reach out on WhatsApp to discuss your background and the right path forward. ## What to do next If you're a B.Pharm graduate considering clinical research, the actionable next steps are: 1. **Decide on the path**—use the diagnostic questions above to pick PV, CRA, CDM, or Medical Coding 2. **Talk to people in the role**—LinkedIn outreach to junior CRAs or PV associates from Pune CROs gives you real ground truth 3. **Choose a training program**—prioritize quality of faculty and placement support over fees 4. **Start fast**—the next batch in any clinical research program is typically the right one. Delaying 6 months is rarely worth it given how the market evolves Clinical research after B.Pharm is one of the highest-leverage decisions a recent graduate can make. The combination of structured training, hireable demand, and rapid compensation growth makes it competitive with any pharma career path—and superior to most. --- # Pune neighborhood guides ## Aundh, Pune **URL:** https://ilearncri.com/locations/aundh/ iLearn CRI's Wakad campus is 15 minutes from Aundh via the Aundh-Ravet BRT corridor, with reliable PMPML bus connectivity and direct arterial road access. **Landmarks:** Aundh ITI Road, Parihar Chowk, Aundh, D.P. Road, Aundh, Savitribai Phule Pune University (SPPU) North Gate, Ruby Hall Clinic, Aundh, Aundh Camp **Transport:** Aundh-Ravet BRT corridor connects Aundh directly to Wakad in approximately 15 minutes, PMPML Route 158 runs from Aundh to Wakad Chowk, PMPML Route 47 connects Aundh to Pimpri, with Wakad interchanges, Mumbai-Pune Expressway access via Wakad connector from Aundh Road, Ola, Uber, and Rapido available from Parihar Chowk and Aundh-Sus Road junction, Pune Metro Line 3 (under construction) Aundh-Wakad segment ## Why students from Aundh choose iLearn CRI Aundh is an established residential neighbourhood with a long-standing academic character — it sits adjacent to Savitribai Phule Pune University and has historically housed students, educators, and graduates working across Pune's institutional and commercial sectors. This academic density means Aundh produces a steady stream of life-sciences graduates each year: B.Sc. graduates from SPPU affiliates, B.Pharm and M.Pharm holders from nearby colleges, and postgraduates in biotechnology and biochemistry. For this population, iLearn CRI's Wakad campus represents a natural next step. The commute via the Aundh-Ravet BRT road is approximately 15 minutes by bike or cab, and the PMPML Route 158 bus makes the journey accessible without a personal vehicle. Students from Aundh who enroll tend to be recent graduates within one to three years of completing their undergraduate or postgraduate degrees, and they are often familiar with the pharma industry through internships, family connections to the sector, or coursework in pharmacology and pharmaceutical sciences. The [Pharmacovigilance Course](/courses/pharmacovigilance/) is the most enrolled programme among Aundh-area students, consistent with its status as the broadest entry point into clinical research for life-sciences graduates. The [CRA Training](/courses/clinical-research-associate-cra/) is the second most popular, particularly among students with M.Pharm or clinical pharmacology backgrounds who are interested in site-management and patient-facing research roles. ## Getting to our Wakad campus from Aundh From Parihar Chowk or D.P. Road in Aundh, the standard route to Wakad follows the Aundh-Ravet BRT road westward. This arterial road is among Pune's better-maintained corridors and has dedicated bus lanes, which makes PMPML Route 158 a reliable commute option. Travel time is 15 minutes by bike outside peak hours and 18–22 minutes by bus accounting for scheduled stops. Students coming from the SPPU North Gate area or Aundh Camp side can take D.P. Road northwest to the BRT junction and then continue to Wakad Chowk. From there, the campus is a short auto-rickshaw or 10-minute walk. For students who prefer cab aggregators, Ola and Rapido are well-represented in Aundh. The Parihar Chowk area in particular has consistent pickup availability. The route avoids central Pune's traffic density entirely, since it runs westward against the primary inbound commute flow. ## Aundh and Pune's pharma corridor Aundh itself does not house significant pharma manufacturing or CRO operations — its land use is predominantly residential, retail, and institutional. However, Aundh's position as a feeder neighbourhood for the Hinjewadi-Wakad corridor makes it directly relevant. Graduates from Aundh enter the clinical research job market and predominantly take positions in Hinjewadi, Wakad, and Bhosari — all reachable from Aundh in under 30 minutes. Hiring partners relevant to Aundh-area graduates include IQVIA, which has Pune operations proximate to the Hinjewadi corridor, and Sun Pharma, which has a Pune-based regulatory and clinical function. Cipla's Pune operations are also within the broader hiring network. For an Aundh-based graduate who completes a programme at iLearn CRI, the employment geography is manageable — none of the primary employers require relocating beyond Pune's western and northwestern zones. The SPPU connection is relevant in another respect: several iLearn CRI faculty and alumni have institutional links to SPPU's pharmacy and biotechnology departments, which gives Aundh graduates a familiarity advantage when navigating the institute's academic culture. ## Course options for Aundh students Aundh students are well-represented across all programmes, with particular density in the following: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. The most-enrolled programme; strong demand from CROs for this function across all experience levels. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. Suited for graduates targeting site management and clinical operations roles. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. High relevance for M.Pharm graduates from the SPPU cluster with pharmaceutical sciences training. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Good fit for B.Sc. graduates with quantitative or IT interests. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Growing interest from postgraduate science candidates. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Fastest route to employment; recommended for candidates who want to enter the workforce quickly. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. Comprehensive programme; preferred by graduates seeking maximum credential weight. ## Visit our Wakad campus Students from Aundh can reach the campus in under 20 minutes on most days. The campus is open for visits on weekdays and Saturday mornings; no prior appointment is required for a general walkthrough. For those who prefer to plan their visit, send a message on WhatsApp and the admissions team will confirm faculty availability and share a maps link for the precise campus location on ITI Road, Wakad. --- ## Balewadi, Pune **URL:** https://ilearncri.com/locations/balewadi/ iLearn CRI's Wakad campus is 10 minutes from Balewadi via the Aundh-Ravet BRT road, making it the nearest clinical research institute for students and professionals in Balewadi and Baner Road. **Landmarks:** Balewadi Stadium (Shree Shiv Chhatrapati Sports Complex), Balewadi High Street, Aundh-Ravet BRT Road (Balewadi section), The Pavilion Mall, Balewadi, Balewadi Phata junction, D.S. Knowledge Park, Balewadi **Transport:** Aundh-Ravet BRT road connects Balewadi to Wakad in approximately 10 minutes, PMPML BRT bus service from Balewadi Phata to Wakad Chowk, Baner Road connects Balewadi to the Baner-Sus Road network for alternate Wakad access, Ola, Rapido, and Uber available from Balewadi High Street and Balewadi Phata, Sus Road connects Balewadi to Punawale and Wakad's western approach ## Why students from Balewadi choose iLearn CRI Balewadi has shifted markedly over the past decade from a semi-rural fringe into a well-developed residential precinct. The area is known for the Shiv Chhatrapati Sports Complex (Balewadi Stadium) and Balewadi High Street's commercial density, but it is also home to a growing population of working professionals and families who have moved from central Pune or Hinjewadi in search of larger residential spaces. That demographic shift has brought a meaningful number of life-sciences graduates into the neighbourhood — people who completed their education in SPPU-affiliated colleges and are now working in adjacent sectors or are actively looking for their first clinical research role. For Balewadi-based candidates, iLearn CRI's Wakad campus is 10 minutes away via the Aundh-Ravet BRT road — one of Pune's more reliable arterial connectors. The BRT road's dedicated bus lanes mean that PMPML commutes on this stretch are comparatively predictable, which matters for a student who needs to attend classroom sessions consistently over a four- to six-month period. Students from Balewadi most frequently enquire about the [Pharmacovigilance Course](/courses/pharmacovigilance/) and the [CRA Training](/courses/clinical-research-associate-cra/). The neighbourhood also sees higher-than-average interest in the [Medical Writing](/courses/medical-writing/) programme, likely reflecting the presence of candidates who have been working in content, documentation, or technical roles in Balewadi's growing corporate ecosystem. ## Getting to our Wakad campus from Balewadi The standard route from Balewadi to iLearn CRI follows the Aundh-Ravet BRT road directly westward to Wakad Chowk. From Balewadi Phata — the main junction at the intersection of Balewadi High Street and the BRT road — the drive to Wakad Chowk takes 8–10 minutes by bike. By BRT bus, the journey is approximately 12–15 minutes with scheduled stops. Students from the Balewadi High Street end of the neighbourhood can also take Baner Road north to connect with Sus Road, which leads to Punawale and then the western approach of Wakad. This alternative route avoids the Balewadi Phata junction and can be faster during morning peak hours if the BRT corridor is congested. Ola and Rapido are well-available from Balewadi High Street, The Pavilion Mall, and Balewadi Phata throughout the day. Students who drive two-wheelers will find the BRT road route straightforward, with the campus reachable in under 10 minutes during off-peak hours. ## Balewadi and Pune's pharma corridor Balewadi's direct presence in the pharma corridor is limited — the neighbourhood functions primarily as a residential and commercial zone rather than an industrial or CRO hub. However, its location between Baner (with IT-pharma overlap companies) and Wakad (the campus neighbourhood, home to several CRO operational offices) places Balewadi graduates in close proximity to the sector's employers. Hiring partners such as Veeda Clinical Research and Lambda Therapeutic Research, both of which recruit from iLearn CRI's placement network, are accessible from Balewadi in under 15 minutes. IQVIA's Pune operations in the Hinjewadi corridor are approximately 20 minutes from Balewadi. For a working professional based in Balewadi who is transitioning into clinical research, commuting to a Wakad or Hinjewadi employer after completing training is a realistic daily scenario. The sports and institutional character of Balewadi — anchored by the international-standard sports complex and several private schools — also attracts a population that values structured training and credentialed outcomes, which aligns with what iLearn CRI's programmes offer. ## Course options for Balewadi students Balewadi students typically choose from the following programmes, with selection shaped by educational background and prior work experience: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. Consistent first choice for life-sciences graduates entering clinical research. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. Targets site management and clinical operations roles with major CROs. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Growing interest from Balewadi candidates with writing or communications backgrounds. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Relevant for candidates from IT or analytics backgrounds in Balewadi's corporate sector. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Suited for B.Pharm graduates with pharma sciences education. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Shortest programme; effective for candidates who want a structured entry point quickly. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. The broadest credential; preferred by candidates targeting senior or multi-functional entry. ## Visit our Wakad campus From Balewadi, the campus is a direct 10-minute drive — one of the shortest commutes from any Pune neighbourhood outside of Wakad itself. Students are welcome to visit on any weekday or Saturday morning. Reach out on WhatsApp for a directions link or to confirm faculty availability before your visit. The Aundh-Ravet BRT bus makes the campus accessible without a personal vehicle for those who prefer public transport. --- ## Baner, Pune **URL:** https://ilearncri.com/locations/baner/ iLearn CRI in Wakad is a 12-minute drive from Baner, making it the most accessible clinical research training institute for graduates and working professionals in Baner and Balewadi High Street. **Landmarks:** Baner Road (Aundh-Baner Link Road), Balewadi High Street, Baner Gaon, Sus Road Junction, Sigma IT Park, Baner, Orchid Hotel Junction, Baner **Transport:** Baner Road connects directly to Aundh and Wakad in approximately 12 minutes by bike or cab, PMPML Route 160 and 149 serve the Baner-Aundh-Wakad stretch, Ola and Uber widely available from Baner Road and Balewadi High Street, Sus Road connects Baner to Wakad via Punawale in under 15 minutes, Aundh-Ravet BRT accessible from Baner Road for onward connectivity ## Why students from Baner choose iLearn CRI Baner has developed into one of Pune's more affluent residential corridors, drawing a population that includes mid-career professionals, returning NRIs, and young graduates from well-regarded institutions. The neighbourhood's proximity to Balewadi High Street and the Aundh-Baner commercial belt means it attracts a mix of students — some fresh from graduation, others with two to five years of work experience who are evaluating a deliberate career pivot into clinical research or pharma. For both groups, iLearn CRI's Wakad campus is a practical choice. The 12-minute drive via Baner Road or Sus Road is manageable on a daily basis, and the commute is not subject to the same volume of traffic as routes into central Pune or Hinjewadi during IT shift hours. Baner-based students who enroll tend to be methodical in their decision-making — they compare programmes, ask detailed questions about placement outcomes, and often arrive having already researched the clinical research sector independently. The [Medical Writing](/courses/medical-writing/) and [Regulatory Affairs](/courses/regulatory-affairs/) programmes attract a proportionally higher share of Baner-area enquiries than from other neighbourhoods, likely reflecting the neighbourhood's concentration of candidates with postgraduate science degrees or prior exposure to documentation-intensive roles. The [CRA Training](/courses/clinical-research-associate-cra/) and [Pharmacovigilance Course](/courses/pharmacovigilance/) remain the most-enrolled programmes overall, however. ## Getting to our Wakad campus from Baner The most direct route from Baner to Wakad follows Baner Road northwest toward Balewadi, then continues on the Aundh-Ravet BRT road toward Wakad Chowk. Total travel time by bike or cab is approximately 12 minutes outside of peak hours. During the evening (5:30–7:30 PM), return traffic from Hinjewadi can slow this stretch by 5–8 minutes. An alternative route via Sus Road cuts through Punawale and arrives at the Wakad end of the campus approach without passing through Balewadi Chowk — useful for students coming from the Sus Road or Baner Gaon side of Baner. This route is typically 12–15 minutes and less congested. PMPML Routes 160 and 149 serve the Baner-Aundh corridor. Students who prefer public transport can take a bus to Aundh and connect onward to Wakad via Route 158 or a short auto-rickshaw ride. Ola and Rapido are consistently available from the Baner Road main corridor and Balewadi High Street. ## Baner and Pune's pharma corridor Baner's direct contribution to the pharma corridor is modest — the neighbourhood is primarily residential and IT-adjacent rather than industrial or pharma-operational. However, its proximity to Hinjewadi (where IQVIA, Parexel, and other CROs maintain operations) and to Wakad (a logistics and pharma-services hub) places Baner graduates within commuting reach of the sector's key employers. Several mid-sized pharma companies, including Glenmark Pharmaceuticals and Wockhardt, recruit through iLearn CRI's placement network for Pune-based roles. Candidates based in Baner who join clinical research functions at these companies typically find that the Hinjewadi-Wakad corridor offices are reachable in 15–20 minutes — comparable to or better than commuting into Pune's central business districts. For working professionals in Baner's IT firms who hold B.Pharm or M.Sc. degrees, the institute's placement outcomes in pharmacovigilance and CDM roles represent a credible path to a domain they trained for at the undergraduate level. ## Course options for Baner students Baner students most frequently enquire about programmes that offer structured, verifiable credentials suitable for both fresh placement and career repositioning: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. High placement volume; most-requested programme across all areas. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. Strong interest from science graduates targeting field-facing roles. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Popular among Baner candidates with strong academic and writing backgrounds. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Suited for B.Pharm and M.Pharm graduates with compliance interest. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Attracts candidates with IT or data-handling backgrounds. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Shorter commitment; good for candidates testing a career pivot before a longer programme. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. Most comprehensive credential; chosen by candidates seeking broad entry points into the sector. ## Visit our Wakad campus Students from Baner are welcome to visit the campus without prior appointment on any weekday. The drive is straightforward via Baner Road toward Balewadi and then Wakad. If you prefer to confirm the best route from your specific location in Baner, send a WhatsApp message and the team will share a real-time directions link. Faculty and admissions staff are available Monday through Saturday, 10 AM to 5 PM. --- ## Hinjewadi, Pune **URL:** https://ilearncri.com/locations/hinjewadi/ Located 8 minutes from Hinjewadi Phase 1 via Hinjewadi-Wakad Road, iLearn CRI is the nearest clinical research training institute for IT professionals and life-sciences graduates in Hinjewadi. **Landmarks:** Hinjewadi Phase 1 Gate (Rajiv Gandhi Infotech Park), Hinjewadi Phase 2 (Wipro, Infosys campuses), Hinjewadi Phase 3 (Maan-Hinjewadi Road), Hinjewadi IT Park Bus Terminal, Wakad Bridge (Hinjewadi flyover), Laxmi Chowk, Hinjewadi **Transport:** Hinjewadi-Wakad Road directly connects Phase 1 gate to Wakad in approximately 8 minutes by cab or bike, PMPML Route 159 from Hinjewadi Phase 1 to Wakad Chowk, IT park shuttle buses from Phase 1 to Wakad Bridge area, Ola, Uber, and Rapido consistently available from Phase 1, 2, and 3 pick-up zones, Metro Line 3 (Hinjewadi-Shivajinagar) under construction — Hinjewadi Phase 1 and Wakad Bridge planned stations ## Why students from Hinjewadi choose iLearn CRI Hinjewadi is home to one of the largest concentrations of IT professionals in India, and a measurable number of those professionals hold undergraduate degrees in pharmacy, biotechnology, or life sciences. Over the past several years, a growing segment of this group has begun actively exploring career transitions into clinical research — a field where their science foundation is directly applicable and where compensation structures can match or exceed mid-level IT roles. iLearn CRI's Wakad campus, 8 minutes by road from Hinjewadi Phase 1, is the most practical training option for this cohort. Working professionals from Hinjewadi who enroll at iLearn CRI typically attend weekend or early-morning batches, which the institute structures specifically to accommodate employed candidates. The commute to Wakad against the peak Hinjewadi IT traffic is straightforward — Hinjewadi-Wakad Road flows inbound toward Wakad during the morning IT rush, meaning a candidate heading to class does not face the same congestion as those heading into the tech parks. Most students from this area commute by two-wheeler and reach the campus in under 10 minutes. Among Hinjewadi-based students, the [Pharmacovigilance Course](/courses/pharmacovigilance/) and the [CRA Training](/courses/clinical-research-associate-cra/) are the most enrolled programmes. IT professionals with data management backgrounds often enquire about the [Clinical Data Management](/courses/clinical-data-management/) course as a more lateral transition, while those with domain writing experience show interest in the [Medical Writing](/courses/medical-writing/) programme. ## Getting to our Wakad campus from Hinjewadi From Hinjewadi Phase 1 gate, the route to iLearn CRI follows Hinjewadi-Wakad Road directly to Wakad, crossing the Wakad Bridge flyover. The drive by bike or cab is approximately 8 minutes outside peak hours and 12–15 minutes during the IT park rush (8:30–10:00 AM and 6:00–7:30 PM). Students who plan their commute around class schedules rather than corporate shift timings typically find the route uncongested. PMPML Route 159 connects Hinjewadi Phase 1 to Wakad Chowk, from where the campus is a short auto or walk away. Ola and Rapido are reliably available at both Hinjewadi Phase 1 and Phase 2 pick-up points. Once Metro Line 3 (Hinjewadi to Shivajinagar) is operational, the Hinjewadi Phase 1 and Wakad Bridge stations will make this commute even more predictable. For students in Hinjewadi Phase 3 (the Maan area), the commute via Mann-Hinjewadi Road to Phase 1 and then to Wakad adds roughly 5–7 minutes to the base travel time. ## Hinjewadi and Pune's pharma corridor Hinjewadi's IT parks house more than just software companies. Several global pharma and CRO firms have embedded India operations within these campuses — pharmacovigilance processing teams, regulatory submissions units, and medical writing functions. IQVIA, one of iLearn CRI's hiring partners, maintains a significant Pune operation that draws from Hinjewadi-area talent. Parexel and ICON also operate from Pune with Hinjewadi-proximate hiring. The overlap between IT capability and pharma process work is a structural feature of this corridor. A candidate who has spent time in data quality or process management at a Hinjewadi IT firm — and then completes a structured clinical research programme — has a differentiated profile relative to a fresh graduate entering the same role. Employers in this cluster actively seek that combination. Companies such as Veeda Clinical Research, Lambda Therapeutic Research, and Syngene International are within the broader hiring catchment of this corridor. Graduates placed by iLearn CRI into these organisations have included candidates who began their professional careers in Hinjewadi's IT sector. ## Course options for Hinjewadi students The course selection for Hinjewadi-based candidates often reflects their existing professional experience: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. The most-enrolled programme among career switchers from IT; structured process work with strong demand from CROs. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Lateral move for IT professionals with SQL, data handling, or QA backgrounds. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. For science graduates targeting field and site management roles. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Suitable for those with technical writing or documentation experience. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Relevant for candidates with pharma manufacturing or compliance exposure. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Shortest programme; strong entry-level placement track record. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. Comprehensive credential covering the full clinical research domain. ## Visit our Wakad campus Candidates from Hinjewadi are welcome to visit the campus on any weekday between 10 AM and 5 PM. If you are a working professional and prefer an after-hours or weekend visit, reach out on WhatsApp and we will arrange a time that fits your schedule. The campus is an 8-minute drive from Hinjewadi Phase 1 — most visitors use Ola or their personal bike. Faculty are available on campus on weekdays to discuss programme structure, batch timings, and placement outcomes. --- ## PCMC (Pimpri-Chinchwad), Pune **URL:** https://ilearncri.com/locations/pcmc/ iLearn CRI in Wakad serves a large pool of life-sciences graduates from PCMC's industrial and educational belt, with a 10-minute commute via the Hinjewadi-Wakad connector. **Landmarks:** Pimpri Camp and Pimpri Chowk, Chinchwad Railway Station, Bhosari MIDC Industrial Area, Akurdi Metro Station (Line 1), Tata Motors Plant, Pimpri, D.Y. Patil International School, Chinchwad **Transport:** Old Mumbai-Pune Highway (NH48) passes through PCMC and connects to Wakad in approximately 10–12 minutes, PMPML Routes 47, 51, and 158 connect Pimpri and Chinchwad to Wakad Chowk, Chinchwad Railway Station on Pune-Mumbai suburban line, with onward auto connectivity to Wakad, Bhosari-Wakad connector road via Hinjewadi-Wakad bypass, Aundh-Ravet BRT corridor accessible from PCMC's southern edge, Akurdi Metro (Line 1) connects PCMC to Pimpri and Nigdi ## Why students from PCMC choose iLearn CRI The Pimpri-Chinchwad Municipal Corporation area is one of India's largest industrial townships, home to a substantial pharma and life-sciences manufacturing base alongside automotive, engineering, and electronics sectors. This industrial character produces a particular kind of life-sciences graduate: candidates who often have family members employed in pharma manufacturing, who have completed B.Pharm degrees from PCMC-area colleges, and who are familiar with the pharma industry as an economic reality rather than an abstract career aspiration. For these graduates, the transition from manufacturing-oriented education to clinical research roles requires structured training in GCP, regulatory frameworks, and clinical operations — which is precisely what iLearn CRI's programmes provide. The campus is 10–12 minutes from central Pimpri via the Old Mumbai-Pune Highway or the Hinjewadi-Wakad connector, making it a commutable daily option. Students from Bhosari, Chinchwad, and Akurdi find the route straightforward and the travel time manageable even on a daily basis over a six-month programme. PCMC sends a proportionally large number of students into the [Pharmacovigilance Course](/courses/pharmacovigilance/) and the [CRA Training](/courses/clinical-research-associate-cra/), both of which directly leverage a pharmaceutical sciences background. The [Regulatory Affairs](/courses/regulatory-affairs/) programme also draws strong interest from B.Pharm graduates in this area who are already familiar with pharmaceutical quality and compliance concepts from their academic training. ## Getting to our Wakad campus from PCMC From Pimpri Chowk or Chinchwad, the most direct route to Wakad follows the Old Mumbai-Pune Highway (NH48) westward, turning toward Wakad via the Bhosari-Wakad connector or through Hinjewadi Phase 1. Total travel time is 10–12 minutes by bike and 12–18 minutes by cab or bus depending on time of day. PMPML Routes 47 and 51 connect central Pimpri to the Wakad corridor. Students from Bhosari or the MIDC area can take Route 158 or a shared auto to Wakad Chowk. Chinchwad Railway Station provides access to the Pune-Mumbai suburban rail network; from Chinchwad station, an auto-rickshaw to Wakad takes approximately 15 minutes via the highway. Students from Akurdi can use Metro Line 1 to Pimpri station and then take a shared auto or bus to Wakad. The Aundh-Ravet BRT road, accessible from PCMC's southern boundary near Ravet, provides an alternative corridor to Wakad without passing through the highway junction. ## PCMC and Pune's pharma corridor PCMC is arguably the industrial heart of Pune's pharma and life-sciences manufacturing sector. The Bhosari MIDC houses multiple pharma and bulk drug manufacturing units. Companies including Lupin, Wockhardt, and Sun Pharma maintain manufacturing or regional operations within PCMC's industrial zones. Cipla has longstanding operations in the broader Pune-PCMC area. For a clinical research graduate based in PCMC, these manufacturers represent accessible employers — particularly for roles in pharmacovigilance, regulatory affairs, and quality assurance functions embedded within manufacturing sites. The Bhosari industrial belt also hosts several mid-sized contract manufacturing organisations (CMOs) and analytical labs that employ CRA and CDM professionals for clinical supply and data functions. The proximity of PCMC's industrial cluster to the Hinjewadi-Wakad CRO corridor means that a PCMC-based graduate has access to two distinct hiring pools: pharma manufacturers in PCMC and contract research organisations in Hinjewadi-Wakad. iLearn CRI's hiring partners span both — from manufacturers like Cipla and Lupin to CROs like IQVIA, Veeda, and Lambda — giving PCMC graduates meaningful placement breadth. ## Course options for PCMC students The pharma and life-sciences background common among PCMC students makes several programmes particularly well-suited: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. High demand from both CROs and pharma manufacturers for this function; strong placement volume. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Directly relevant for B.Pharm graduates with pharmaceutical manufacturing and quality exposure. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. Site management roles in clinical trials; strong demand from CROs hiring in Pune. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Relevant for candidates with data or IT exposure from engineering or science backgrounds. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Accessible entry point with strong near-term placement outcomes. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Less common among PCMC students but growing in enquiry volume. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. Comprehensive credential; chosen by candidates who want the widest hiring applicability. ## Visit our Wakad campus Candidates from PCMC — whether in Pimpri, Chinchwad, Bhosari, or Akurdi — can visit the campus within a 15-minute drive on most days. The campus is open Monday through Saturday; walk-in visits are welcome during working hours. Send a WhatsApp message for a precise directions link from your PCMC location or to schedule a conversation with an admissions advisor. Candidates from the MIDC belt who work irregular shifts can arrange evening or Saturday consultations upon request. --- ## Pimple Saudagar, Pune **URL:** https://ilearncri.com/locations/pimple-saudagar/ iLearn CRI's Wakad campus is 7 minutes from Pimple Saudagar, making it the closest clinical research institute for B.Pharm and life-sciences graduates in the area. **Landmarks:** Pimple Saudagar Main Road, Spine Road, Pimple Saudagar, Sangvi Phata junction, D-Mart Pimple Saudagar, KPIT Technologies campus (nearby), Wakad Bridge approach from Pimple Saudagar Road **Transport:** Pimple Saudagar Road connects directly to Wakad Chowk in approximately 7 minutes by bike, PMPML Route 47 and 158 connect Pimple Saudagar to Wakad corridor, Sangvi Phata to Wakad via Aundh-Ravet BRT road junction — under 10 minutes, Auto-rickshaw and Ola/Rapido widely available from Pimple Saudagar Main Road, Old Mumbai-Pune Highway (NH48) accessible via Spine Road for PCMC connectivity ## Why students from Pimple Saudagar choose iLearn CRI Pimple Saudagar is a family-oriented residential neighbourhood that has grown significantly over the past decade, drawing populations from PCMC's industrial belt who want residential access to Pune's western corridor without the cost of Baner or Balewadi. The area has a strong pharmacy graduate presence — several B.Pharm students from Pimpri-Chinchwad area colleges settle in Pimple Saudagar after completing their degrees, and many are actively looking for postgraduate clinical research training within a short commute. At 7 minutes from Wakad, iLearn CRI is the nearest clinical research institute for Pimple Saudagar residents. That proximity matters: a B.Pharm graduate who has spent four years commuting to a college in PCMC understands the value of a campus they can reach quickly, and the 7-minute ride on Pimple Saudagar Road to Wakad Chowk is among the most convenient commutes of any neighbourhood in this guide. The student profile from Pimple Saudagar skews toward recent B.Pharm and B.Sc. graduates in the 21–25 age range, many of whom are choosing between a clinical research programme and an M.Pharm admission. For those who choose clinical research, the [Pharmacovigilance Course](/courses/pharmacovigilance/) is the most enrolled programme, followed by the [CRA Training](/courses/clinical-research-associate-cra/). Several students who completed B.Pharm from PCMC colleges also opt for the [Regulatory Affairs](/courses/regulatory-affairs/) programme, given their prior familiarity with pharmaceutical quality and compliance coursework. ## Getting to our Wakad campus from Pimple Saudagar The route from Pimple Saudagar to Wakad is straightforward. From the main Pimple Saudagar Road or Spine Road, students head southwest toward Wakad Chowk, crossing the Pimple Saudagar-Wakad connector stretch. Total travel time is 7 minutes by bike or 10 minutes by cab or auto during normal conditions. The Sangvi Phata junction provides access to the Aundh-Ravet BRT road, which continues to Wakad. This route is slightly longer but avoids the Pimple Saudagar Road if congested. PMPML Routes 47 and 158 both serve the Pimple Saudagar corridor and connect to Wakad Chowk, from where the campus is reachable by auto in 3–5 minutes. Ride-share services — Ola, Uber, and Rapido — have good availability on Pimple Saudagar Main Road throughout the day. Auto-rickshaws from the Sangvi Phata or D-Mart area provide an economical alternative for the short commute. ## Pimple Saudagar and Pune's pharma corridor Pimple Saudagar sits at the intersection of two important corridors: the PCMC industrial belt to the north (Bhosari, Chinchwad, Pimpri) and the Hinjewadi-Wakad IT-pharma corridor to the west. This dual proximity is relevant to clinical research graduates — the PCMC side offers pharma manufacturing employers like Lupin, Wockhardt, and Sun Pharma's Pune operations, while the Wakad-Hinjewadi side offers CRO employers like Veeda, Lambda, and IQVIA. Pimple Saudagar's KPIT Technologies campus and surrounding IT offices also create a small pool of IT professionals with B.Pharm backgrounds who are considering domain transitions. These candidates often enroll in evening or weekend batches at iLearn CRI while continuing to work, and they typically target CDM or pharmacovigilance roles where their IT and data skills complement the clinical research training. For fresh graduates from B.Pharm colleges in the broader PCMC catchment who live in Pimple Saudagar, the 7-minute commute to iLearn CRI and the 15–20 minute commute to PCMC pharma employers represent a coherent geography — training and employment are both within reach of their home neighbourhood. ## Course options for Pimple Saudagar students B.Pharm and life-sciences graduates from Pimple Saudagar are well-matched with several programmes: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. The most enrolled programme from this area; strong placement demand from both CROs and pharma manufacturers. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Particularly relevant for B.Pharm graduates with pharmaceutical quality coursework from PCMC colleges. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. Growing interest from Pimple Saudagar graduates targeting clinical operations roles. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Strong fit for candidates with IT or data background from Pimple Saudagar's corporate sector. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Fastest path to employment; frequently chosen by candidates who want to enter the workforce before considering a longer programme. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Increasingly popular among postgraduate science candidates. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. Comprehensive credential for those seeking the widest hiring access. ## Visit our Wakad campus Pimple Saudagar students have one of the shortest commutes to campus of any neighbourhood in Pune — 7 minutes on a typical day. Walk-in visits are welcome Monday through Saturday, 10 AM to 5 PM. For a specific directions link from your location in Pimple Saudagar, or to confirm a faculty consultation, message us on WhatsApp. The team responds within the hour on working days. --- ## Tathawade, Pune **URL:** https://ilearncri.com/locations/tathawade/ iLearn CRI in Wakad is 6 minutes from Tathawade — making it the nearest clinical research institute for life-sciences graduates from MIT-WPU, JSPM, Indira College, and other Tathawade-area institutions. **Landmarks:** MIT World Peace University (MIT-WPU), Tathawade, JSPM Narhe Technical Campus (Tathawade Road), Indira College of Pharmacy, Tathawade, Tathawade Chowk, Hinjewadi-Tathawade Road junction, Tathawade IT Park (TCS and Persistent campus) **Transport:** Tathawade-Wakad Road connects directly to Wakad in approximately 6 minutes by bike, PMPML routes connecting Tathawade to Hinjewadi Phase 1 and Wakad corridor, Hinjewadi-Tathawade-Wakad connector via Punawale — under 10 minutes, Ola and Rapido available from MIT-WPU gate and Tathawade Chowk, Old Mumbai-Pune Highway (NH48) accessible via Tathawade Road for PCMC connectivity ## Why students from Tathawade choose iLearn CRI Tathawade is a university-dense neighbourhood that produces a large and consistent pipeline of life-sciences graduates every year. MIT World Peace University (MIT-WPU), JSPM institutions, and Indira College of Pharmacy are all located in or directly adjacent to Tathawade. These colleges collectively graduate hundreds of B.Pharm, M.Pharm, B.Sc. Biotechnology, and allied health sciences students annually — students who need structured, industry-aligned postgraduate training to transition into clinical research roles. For this specific population, the 6-minute commute from Tathawade to iLearn CRI's Wakad campus is a significant practical advantage. The Tathawade-Wakad Road connects the two neighbourhoods directly, and the route is one of the shortest and least congested in Pune's western corridor. Students who live in university hostels or in Tathawade's residential pockets near MIT-WPU can reach the campus faster than many students who live in Pune's central neighbourhoods. The volume of students from Tathawade at iLearn CRI reflects this geography. Graduates from Indira College of Pharmacy make up a notable segment of the Regulatory Affairs and Pharmacovigilance cohorts. MIT-WPU graduates from biotechnology and pharmaceutical sciences programmes are well-represented in the CRA and CDM batches. The [Pharmacovigilance Course](/courses/pharmacovigilance/) is the single most enrolled programme from this area, consistent with its position as the most accessible entry point into clinical research for a broad range of science graduates. ## Getting to our Wakad campus from Tathawade From Tathawade Chowk or the MIT-WPU main gate, the route to iLearn CRI follows Tathawade-Wakad Road southward and westward into Wakad. The drive by bike is approximately 6 minutes; by auto-rickshaw or cab, approximately 8–10 minutes. This is one of the shortest commutes from any institutional neighbourhood in Pune. Students from the JSPM campus or the Hinjewadi-Tathawade junction side can also route via the Hinjewadi-Tathawade connector to Hinjewadi Phase 1 and then take Hinjewadi-Wakad Road to the campus. This route is slightly longer but can be more familiar for students who commute through Hinjewadi regularly. PMPML bus connectivity exists between Tathawade and the Wakad corridor, though most students from this area use two-wheelers or shared autos given the short distance. Ola and Rapido are available from MIT-WPU gate and Tathawade Chowk. The Old Mumbai-Pune Highway is accessible via Tathawade Road for students who need to connect through PCMC or Bhosari. ## Tathawade and Pune's pharma corridor Tathawade's contribution to the pharma corridor is primarily educational — the neighbourhood is a production point for life-sciences talent rather than a location of pharma manufacturing or CRO operations. However, this makes Tathawade one of the most strategically important source neighbourhoods for iLearn CRI: graduates from MIT-WPU, Indira College of Pharmacy, and JSPM enter the hiring market each year in significant numbers, and those who complete a structured clinical research programme are competitive candidates for positions throughout the Hinjewadi-Wakad-Bhosari corridor. The Tathawade IT Park, home to TCS and Persistent Systems campuses, also employs IT professionals who hold pharmacy or life-sciences degrees — a cohort that occasionally pursues clinical research training for career repositioning. This is less common than in Hinjewadi but is a recognisable pattern. Hiring partners relevant to Tathawade graduates include Syngene International, Veeda Clinical Research, and Mylan (now Viatris India) — all of which recruit from iLearn CRI's placement network for Pune-based roles. Lambda Therapeutic Research and IQVIA are also within the hiring geography. Tathawade graduates placed by iLearn CRI have entered these organisations in pharmacovigilance analyst, clinical data associate, and junior CRA roles. ## Course options for Tathawade students Tathawade's institutional density makes the area particularly well-matched with programmes that build on pharmaceutical and life-sciences foundations: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. The most-enrolled programme; directly applicable for B.Pharm and M.Pharm graduates from Indira College and JSPM. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. High demand from MIT-WPU biotechnology and pharmaceutical sciences graduates. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Strong alignment with pharmaceutical sciences training from Indira College of Pharmacy; one of the most recommended programmes for Tathawade's pharmacy graduates. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Suited for graduates with data, statistics, or IT coursework — a common combination at MIT-WPU. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Frequently chosen by Tathawade graduates who want to begin working within 3 months of completing their degree. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. Growing interest from postgraduate students with strong English and academic writing backgrounds. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. The most comprehensive credential; chosen by graduates who want to delay specialisation and retain optionality across clinical research functions. ## Visit our Wakad campus For students from Tathawade — whether based at MIT-WPU, Indira College of Pharmacy, JSPM, or in the surrounding residential areas — the campus is a 6-minute ride from your front door. Walk-in visits are welcome on all weekdays and Saturday mornings. If you want to arrange a conversation with a specific faculty member or get a maps link for your exact starting point in Tathawade, send us a message on WhatsApp. The admissions team is available Monday through Saturday between 10 AM and 5 PM. --- ## Wakad, Pune **URL:** https://ilearncri.com/locations/wakad/ iLearn CRI's main campus is in Wakad, making it the most accessible clinical research training institute for students and working professionals in the area. **Landmarks:** Wakad Chowk, ITI Road, Wakad, Kaspate Vasti Road, Wakad Bridge (Hinjewadi flyover approach), Xion Mall, Wakad, D-Mart Wakad **Transport:** PMPML Route 158 and 159 connect central Pune and Hinjewadi to Wakad, Direct auto-rickshaw and cab access from Hinjewadi Phase 1 gate (approx. 8 min), Mumbai-Pune Expressway access via Wakad-Bhosari connector road, Aundh-Ravet BRT corridor passes through Wakad, Metro Line 3 (Hinjewadi-Shivajinagar) planned stop near Wakad Bridge ## Why students from Wakad choose iLearn CRI iLearn CRI's campus is located in Wakad, which means students from this neighborhood face zero commute friction. Whether you live near Wakad Chowk, Kaspate Vasti, or the ITI Road stretch, the campus is within walking distance or a short auto-rickshaw ride. That proximity is a practical advantage that many students cite when they choose to enroll — a 6-month or 12-month programme demands consistent attendance, and living in the same neighbourhood removes one of the more common logistical barriers. Wakad has evolved over the past decade into a dense residential and commercial belt that straddles the Pune-Hinjewadi IT corridor. The population here skews young and educated — life-sciences graduates from SPPU affiliates, pharmacy diploma holders, and B.Sc. Biology or Biotechnology graduates looking for structured career pathways into the pharma and clinical research sector. For that demographic, an institute they can reach on foot or in under ten minutes by auto is a meaningful factor. The two most popular programmes among Wakad-area students are the [Pharmacovigilance Course](/courses/pharmacovigilance/) and the [CRA Training](/courses/clinical-research-associate-cra/). Both are six-month classroom programmes that align well with the Hinjewadi-Wakad pharma and CRO hiring corridor. Students who have already spent time working in IT or adjacent sectors sometimes opt for the [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/), which provides the broadest credential across all clinical research functions. ## Getting to our Wakad campus from Wakad If you live in Wakad, you likely already know the campus area. The institute is situated near ITI Road — a central spine of Wakad that connects D-Mart on one end to the Hinjewadi flyover approach on the other. From Wakad Chowk, most students arrive on foot in 5–10 minutes or take a short auto ride. There is no meaningful traffic concern for local students outside of peak IT-corridor rush hours between 9–10 AM and 6–7 PM. For students near Kaspate Vasti or the Xion Mall end of Wakad, an auto or bike takes under five minutes. PMPML Routes 158 and 159 serve the broader Wakad corridor, making the campus accessible from Hinjewadi Phase 1, Aundh, and points beyond. Ride-share availability through Ola and Rapido is consistent throughout the day. ## Wakad and Pune's pharma corridor Wakad sits at the western edge of what practitioners in the industry informally call the Hinjewadi-Wakad-Bhosari pharma and CRO corridor. Several contract research organisations and pharma companies maintain operational offices or regional presence in and around this zone, including Veeda Clinical Research, Lambda Therapeutic Research, and IQVIA. These are not distant employers — for a student living in Wakad, many entry-level CRA, PV analyst, and data management positions are within a 15-minute commute of home. The Hinjewadi IT parks also house regulatory affairs teams and medical writing units for global pharma companies that have embedded their India operations within the tech campuses. Graduates from iLearn CRI have been placed in such roles across multiple Hinjewadi-based employers, which reinforces the practical relevance of studying clinical research while based in Wakad. ## Course options for Wakad students Wakad students benefit from the full course catalogue, all delivered from the same campus. The programmes most frequently enquired about are: - [Pharmacovigilance Course](/courses/pharmacovigilance/) — 6 months, ₹84,000. Strong placement demand from CROs in the corridor. - [CRA Training](/courses/clinical-research-associate-cra/) — 6 months, ₹96,000. Suited for science graduates targeting site management roles. - [Clinical Data Management](/courses/clinical-data-management/) — 4 months, ₹72,000. Relevant for graduates with data or IT exposure. - [Medical Coding](/courses/medical-coding/) — 3 months, ₹42,000. Fastest path to a structured clinical research entry role. - [Medical Writing](/courses/medical-writing/) — 4 months, ₹66,000. For graduates with strong English and science backgrounds. - [Regulatory Affairs](/courses/regulatory-affairs/) — 5 months, ₹84,000. Relevant for pharma graduates eyeing compliance functions. - [PG Diploma in Clinical Research](/courses/pg-diploma-clinical-research/) — 12 months, ₹1,68,000. The broadest credential; suitable for those targeting senior or generalist roles. ## Visit our Wakad campus If you live in Wakad and want to visit the campus, no appointment is necessary for a general enquiry visit during working hours. You can also reach us on WhatsApp for precise directions from your location — our team will send a maps pin and confirm available faculty for a campus walkthrough. There is ample parking near the campus for two-wheelers, and auto-rickshaws are available from Wakad Chowk at all hours. --- # Faculty profiles ## Dr. Radhika Iyer — Faculty Lead — Pharmacovigilance **URL:** https://ilearncri.com/faculty/dr-radhika-iyer/ **Years of experience:** 12+ **Qualifications:** M.Pharm (Pharmacology), Diploma in Pharmacovigilance (JLI), Argus Safety Certification **Expertise:** ICSR processing and case management, Argus Safety database (admin-level), Aggregate safety reporting (PSUR, PBRER, DSUR), Signal detection and disproportionality analysis, MedDRA coding Dr. Iyer leads the Pharmacovigilance curriculum at iLearn CRI, drawing on twelve years of practice across Cipla, Veeda Clinical Research, and a global CRO's India delivery centre. She has personally processed over 4,000 ICSRs, written aggregate reports for 15+ marketed products, and led signal detection workflows for an oncology portfolio. Her teaching style is built around real cases — the unusual SAEs, the difficult causality assessments, the audit findings that taught her how the work actually gets done versus how the textbooks describe it. Students consistently rate her case-based teaching as the strongest part of the Pharmacovigilance course. --- ## Anand Deshmukh — Faculty Lead — Clinical Research Associate Training **URL:** https://ilearncri.com/faculty/anand-deshmukh/ **Years of experience:** 9+ **Qualifications:** M.Pharm (Pharmaceutics), ICH-GCP Certification (TransCelerate), Veeva Vault CTMS Practitioner **Expertise:** Site monitoring and SDV, Risk-based monitoring (RBQM), ICH-GCP E6(R3) implementation, Trial Master File (TMF) management, Veeva Vault CTMS and Medidata Rave Anand has spent nine years as a Clinical Research Associate, progressing from CRA Level I at a mid-tier CRO to CRA Level III at a global CRO leading site monitoring for a Phase III oncology trial across 14 sites in Maharashtra and Gujarat. He teaches the CRA module at iLearn CRI from active practice — his monitoring reports, his protocol deviations files, his closeout visit checklists. He brings in current CRO escalations as anonymised case studies, ensuring students are trained on the issues hiring managers ask about today, not the textbook scenarios from a decade ago. --- ## Dr. Priya Menon — Faculty Lead — Medical Writing **URL:** https://ilearncri.com/faculty/dr-priya-menon/ **Years of experience:** 11+ **Qualifications:** PhD (Pharmaceutical Sciences), Certificate in Regulatory Medical Writing, AMWA Essential Skills Certificate **Expertise:** Clinical Study Reports (CSRs) — ICH E3, Clinical trial protocols (SPIRIT), Manuscript writing and peer review response, Patient narratives for SAEs, DSUR / PSUR aggregate writing Dr. Menon brings eleven years of regulatory and publication writing across IQVIA, Parexel, and her current role as a senior writer at a Pune-based generics sponsor. She has authored 30+ peer-reviewed manuscripts and led writing on a dozen CSRs accepted in USFDA submissions. She teaches the Medical Writing course from her own delivered work, walking students through real CSR sections, manuscript drafts, and reviewer response letters. Her admission writing test screens for the foundation she expects every student to build on, and her mentoring frequently leads top students to publication during the course itself. --- ## Sanjay Patil — Faculty Lead — Regulatory Affairs **URL:** https://ilearncri.com/faculty/sanjay-patil/ **Years of experience:** 13+ **Qualifications:** M.Pharm (Quality Assurance), RAC (Regulatory Affairs Certification), Lorenz docuBridge Practitioner **Expertise:** USFDA ANDA and DMF submissions, EMA centralised and decentralised procedures, CTD / eCTD compilation, CDSCO regulatory pathways, Post-approval lifecycle management Sanjay leads the Regulatory Affairs curriculum at iLearn CRI, drawing on thirteen years across Lupin, Glenmark, and a Pune-based regulatory consulting boutique. He has personally compiled 60+ ANDAs, 25+ DMFs, and led EMA marketing authorisation submissions for biosimilars portfolios. He teaches the regulatory module from current work — recent FDA Form 483 responses, active variation submissions, current CDSCO SUGAM filings — ensuring students learn the regulatory landscape as it actually is in 2026, not the framework that was taught a decade ago. --- ## Meera Kulkarni — Faculty Lead — Clinical Data Management **URL:** https://ilearncri.com/faculty/meera-kulkarni/ **Years of experience:** 9+ **Qualifications:** M.Sc (Bioinformatics), Medidata Rave Certified, SAS Base Programming Certified, CDISC SDTM Implementation Workshop **Expertise:** Medidata Rave study build and form design, CDISC standards: CDASH, SDTM, ADaM, Discrepancy management and reconciliation, Database lock procedures, Base SAS programming for clinical data Meera teaches the Clinical Data Management curriculum at iLearn CRI, drawing on nine years across IQVIA and Syngene as a Senior Clinical Data Manager. She has built and locked databases for 25+ trials across oncology, cardiovascular, and metabolic disorders, and has led SDTM mapping for a dozen FDA submissions. Her teaching is heavily hands-on — students complete a real Rave study build, write annotated CRFs, and walk through SDTM mapping exercises under her guidance. The portfolio they develop during the course is what gets them through CDM hiring tests at Pune CROs. --- ## Rohan Bhatt — Faculty Lead — Medical Coding **URL:** https://ilearncri.com/faculty/rohan-bhatt/ **Years of experience:** 8+ **Qualifications:** B.Pharm, AAPC CPC (Certified Professional Coder), AAPC CIC (Certified Inpatient Coder) **Expertise:** ICD-10-CM coding (all body systems), CPT coding including E/M and surgery, HCPCS Level II, Risk adjustment / HCC coding, AAPC CPC exam preparation Rohan leads the Medical Coding curriculum at iLearn CRI, drawing on eight years of production coding and quality auditing across Cognizant and Optum. He maintains AAPC CPC and CIC certifications and has personally coded over 30,000 charts across emergency department, outpatient surgery, and inpatient settings. His teaching is exam-focused and case-driven — students sit timed coding tests on real anonymised charts each week, and the course's CPC pass rate among prepared students is among the highest in Pune. He also covers the freelance and remote-work pathways that distinguish medical coding from other clinical careers. ---